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RED SUNSHINE: A Story of Strength and Inspiration from a 
Doctor Who Survived Stage 3 Breast Cancer, by Kimberly Allison, 
M.D. ’01 (Hatherleigh Press, 2011). In 2008, Dr. Kimberly Allison 
was 33, the mother of two small children, and an instructor of 
pathology at the University of Washington in Seattle when she 
was diagnosed with an advanced and virulent form of breast can-
cer. Looking for books about how it actually felt to go through 
cancer treatment, she found none. Now cancer-free, Dr. Allison 
wrote Red Sunshine as a memoir about her journey from physi-
cian to patient, her struggle to regain her health and her attempt 
to make the most of a frightening and unexpected ordeal.
Kimberly Allison, M.D., is Director of Breast Pathology at the 
University of Washington Medical Center in Seattle, where she continues to help women as 
they deal with breast cancer. She is actively involved in breast cancer research, clinical diag-
nostics, and teaching.
MAKING SENSE OF AUTISM SPECTRUM DISORDERS:  
Create the Brightest Future for Your Child with the Best Treatment 
Options, by James Coplan, M.D. ’73 (Bantam, 2010). A develop-
mental pediatrician who has worked with children on the autism 
spectrum for more than 30 years, Dr. Coplan presents a detailed 
analysis of the disorder. In Part I, he discusses causes and symp-
toms. Part II focuses on treatment, including a thorough examina-
tion of behavior management techniques and medications, and in 
Part III the focus is on the family as the child ages. The book also 
addresses the many conflicting claims regarding the cause of 
autistic spectrum disorder, proved and unproved interventions,  
and possible reasons for the so-called “explosion” of cases of ASD.
A resident of Philadelphia, James Coplan, M.D., has a private pediatric practice for children 
with developmental disabilities. He also holds two faculty appointments at the University  
of Pennsylvania.
MANUAL FOR EYE EXAMINATION AND DIAGNOSIS  
(8TH EDITION), by Mark W. Leitman, M.D. ’71 (Wiley-Blackwell, 
2012). Written for health professionals and students, this short, 
well-illustrated manual, now in its 8th edition, offers a concise 
introduction to eye diagnosis and treatment. The text sum-
marizes key points needed to understand basic examination 
techniques, use of instruments and major ophthalmic dis orders. 
There are chapters discussing the latest information on 
refractive surgery, glaucoma surgery and neuro-ophthalmology,  
and covers tests such as optical coherence tomography and 
optic nerve fiber scanning.
Mark W. Leitman, M.D., has been practicing ophthalmology for 
more than 30 years. Specializing in cataract and glaucoma surgery, he is an attending physi-
cian at St. Peter's University Hospital in New Brunswick, N.J., and at Robert Wood Johnson 
Surgicenter in East Brunswick. He has a special interest in researching changes in circadian 
intraocular pressure. n
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Y ou lose some, you win some.It may sound corny, but in the arena of pediatric  cancer research at New York Medical College, this  
is exactly what happened. Somasundaram Jayabose, M.D.,  
the original chief architect of a division that had become a 
regional destination for children diagnosed with leukemia and 
other fatal cancers, retired from a distinguished career in pediat-
ric hematology-oncology at the College and Westchester 
Medical Center. In 2009, after more than 30 years on the job, 
Dr. J, as he was called by his patients, brought the research 
and treatments he had developed in America back to his native 
India, where he opened a pediatric oncology center. Meanwhile 
in Valhalla, the search for a replacement had begun in earnest. 
This time the hunt was on for someone with an outstanding 
track record in cellular therapeutics.
Enter pediatrician-scientist Mitchell S. Cairo, M.D., formerly of 
Columbia University, Georgetown University and points west, 
who joined New York Medical College about a year ago with 
his team of 16 laboratory and administrative personnel. 
Dr. Cairo has signed on for an impressive array of responsibili-
ties. At Westchester Medical Center he is chief of pediatric 
hematology, oncology and stem cell transplantation, and 
director of the Children and Adolescent Cancer and Blood 
Diseases Center. Here at the College he holds professorships in 
five disciplines: pediatrics, medicine, pathology, microbiology 
and immunology and cell biology and anatomy. And for the 
record, Dr. Cairo has delivered more than 800 national and 
international presentations and written more than 300 peer-
reviewed publications.
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“Dr. Cairo has a fabulous reputation. We knew we had to take 
what Dr. Jayabose accomplished to the next level,” says Michael 
S. Gewitz, M.D., professor of pediatrics and vice chairman of 
the Department of Pediatrics. Dr. Gewitz is physician-in-chief at 
Maria Fareri Children’s Hospital at Westchester Medical Center. 
He and Leonard J. Newman, M.D. ’70, department chair, share 
responsibilities for running the second largest department at 
the College. To replace Dr. Jayabose, Drs. Gewitz and Newman 
needed someone who would not just follow the protocols, but 
could create them.
WHAT THE DOCTOR ORDERED
Says Dr. Gewitz, “Here is a perfect example of how much can 
be accomplished when all the parties are in agreement. The 
research facilities Dr. Cairo needs are available at the College, 
and the clinical services are supplied by the medical center and 
its children’s hospital. But what helps make it all work is the  
extensive pediatric network we have established all over the 
Hudson Valley and Connecticut. By the end of 2011, the clinical 
practice component of the department will have more than 200 
physicians at 20 locations. The headquarters is on the Valhalla 
campus. The entire program represents a significant invest-
ment in children’s health for the entire region and speaks well 
for the future.”
“I am impressed with the legacy that Dr. Jayabose left. It is a 
state-of-the-art clinical program,” says Dr. Cairo. “My plan is to 
enhance the development of novel therapies—especially stem 
cell transplantation. I want to develop a fellowship program 
[recently approved by the Accreditation Council of Graduate 
Medical Education (ACGME)] that will expand the bench-to-
bedside program. And besides the Department of Medicine, 
there are other opportunities in the departments of Microbiology 
and Immunology, Cell Biology and Anatomy and Pathology. 
We’re trying to bring the basic sciences and the clinical  
Mitchell S. Cairo, M.D., 
moved his team and 
expertise to Valhalla, 
where opportunity is the 
operative word.
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departments home together.” He has made a good beginning 
by establishing the President’s Molecular and Translational 
Research Seminar series last October, and the Assistant 
Professors’ Basic, Clinical and Translational Research 
Symposium, scheduled for late winter.
NOT BUSY ENOUGH
When it comes to the inevitable question about why he would 
leave Columbia, where he spent the last 11 years, the Armonk 
resident says enthusiastically, “First of all, my commute is half 
of what it was. But seriously, [the position at NYMC] presented 
a tremendous opportunity to further develop the programs  
in pediatric hematology, oncology, stem cell transplantation, 
tumor immunology, stem cell biology and regenerative therapy, 
with many more expanded opportunities. All this will be value 
added to the research mission of the project. I’ve been working 
with Karen Seiter [M.D. ’85, professor of medicine and chief of 
the leukemia service] on this and she is a great asset.”
Dr. Cairo’s success in making multi-tasking into a fine art is 
credited to his division of labor into quarters: “I work 12 to 16 
hour days and that includes weekends. I spend 25 percent  
on teaching, 25 percent on research, 25 percent on seeing 
patients, and 25 percent on the administrative responsibilities 
that go into all of my titles. If I had to give up something, the 
last thing would be taking care of patients.” In October he pre-
sented at the Society International Pediatric Oncology in New 
Zealand, and in November he was invited to the Vatican for a 
conference on “Adult Stem Cells: Science and Future of Man 
and Culture.”
“I believe I was one of the few pediatric hematologists- 
oncologists invited. I wasn’t aware that my work was recog-
nized by the Vatican until I got the invitation,” he says quietly.
STEM CELL THERAPY
“We are investigating stem cell therapy for neurologic and  
cardiac uses—for example, babies with the congenital heart 
disease hypoxia, with and without neurological injury. In 12 to 
24 months we hope to have designed immune cells for treating 
specific cancers such as leukemia, lymphoma and neuroblas-
toma, dispensing them to patients in the clinical setting. There 
would be different products for different diseases,” he reveals. 
“The plans include a state-of-the-art laboratory at Westchester 
Medical Center that must meet federal regulations for stem cell 
and gene therapy. Architectural drawings are complete and 
construction of the 8,000 square foot space should begin soon 
in a medical center building. There are only a half dozen facili-
ties like it in the country.”
NO TIN MAN
With so many balls in the air, you might think Dr. Cairo would 
be partial to one of his studies, but he claims to have no  
favorites. Still, the cellular and tissue engineering laboratory 
(they call it C-TEL) has a special place in his heart. And heart 
he has, along with a brain that thinks outside the box. “When I 
was a med student I was always seeing kids with brain tumors 
and sickle cell disease. Then and there I decided I wanted  
to take care of these children. At that time, there was a 20  
percent survival rate—with chemo and radiation. Now we  
cure 90 percent of kids with lymphoma.”
His creative mentality may be his greatest asset. He tells the 
story of a year-old child born with epidermolysis bullosa, “a 
very bad disease caused by a defect in collagen from the 7A 
gene. The skin separates into layers and blisters form con-
stantly; the prognosis is terrible.” A research dermatologist with 
an appointment in human genetics, Angela Christiano, Ph.D., 
knew of Dr. Cairo’s work in stem cell transplantation but didn’t 
know him personally, though they worked in the same building 
at Columbia. She approached him, and was rewarded with his 
assent to helping her treat the child. “Most people of his stature 
would not have even met with me, but Dr. Cairo said yes to the 
meeting and yes to the procedure. It turned out to be the first 
stem cell transplantation performed for a skin disease,” she 
says. “He has this amazing team who handle everything. One 
of them, a clinical research nurse, has worked with him for  
30 years. Every single one left Columbia to continue working 
with him.”
And the little boy with the horrible skin disease? “His brother 
was a perfect match. He is 3 now. His skin is healing and he  
is gaining weight nicely,” she says. The novel way Dr. Cairo 
04 : :  Fall/Winter 2011
applies the transplantation procedure to other diseases has 
earned him fame, and he is credited with having performed  
the first infusion for sickle cell disease.
LIVE IMAGING
One thing he couldn’t bring with him from his last job is the 
$400,000 imaging system, considered essential for sophisti-
cated research, that tracks cell populations in vivo—especially 
in stem cell and cancer biology. Pediatrics bought him his own 
machine, which is available for use by other departments for a 
fee and the proper credentials. This camaraderie from the new 
guy in town has not escaped notice by faculty who are eager 
to give him his due.
Joseph D. Etlinger, Ph.D., professor and chair of the Depart-
ment of Cell Biology and Anatomy, gave Cairo a secondary 
appointment in his department. Now he’s first in line to study 
blood perfusion in animals with spinal cord injuries, along with 
cell biology and anatomy colleagues Richard Zeman, Ph.D., 
associate professor, and Abraham Brown, Ph.D., research 
associate professor.
In looking back on his road to success, there was little reason 
to suspect that Dr. Cairo would wind up on the East Coast. His 
pronunciation of certain words betrays his Chicago upbringing,  
no doubt nurtured by his undergraduate years at the University 
of Wisconsin. But when he opted for a warmer climate for 
medical school, he chose the University of California at San 
Francisco, and again for the year he was chief resident. He did 
his residency at UCLA, and following a two-year fellowship at 
the University of Indiana sponsored by the American Cancer 
Society, he returned to the University of California in 1981 for 
his first academic appointment, assistant professor. He stayed  
for 16 years, accumulating the experience and skills that earned 
him the titles and acclaim. When he departed California in 
1997, he was Medical Director, Children’s Hospital of Orange 
County/St. Joseph Hospital Pediatric and Adult Unrelated 
Bone Marrow Transplant and Collection Program.
BACK EAST
Georgetown University brought him east as a full professor and 
Chief, Division of Stem Cell Transplantation, Cellular and Gene 
Therapy. He also accepted the role of medical director for the 
National Marrow Donor Program, Unrelated Transplantation 
Program. He left Georgetown in March of 2000 and joined 
Columbia University and its New York-Presbyterian Hospital. 
After 11 years there, he accepted the official position of 
Hematology/Oncology Chief and Associate Chairman for 
Translational Research of the Department of Pediatrics at  
New York Medical College, plus duties that justify all the other 
titles on his list.
Besides his cohort from Columbia, Dr. Cairo brought with him 
everything he needs to thrive in his new digs. This includes two 
major grants, one from the St. Baldrick’s Foundation at nearly 
$1 million per year, and another from the Pediatric Research 
Foundation, $1 million a year for three years. The refreshing 
aspect to his work is that he is still actively caring for patients.
“I do take care of patients—but only at Maria Fareri Children’s 
Hospital. I hit the ground running when I got here—ten trans-
plants in ten weeks. I used to do ten in two years!” he says 
almost in disbelief. The St. Baldrick’s funds are earmarked  
for lymphoma, the most common cancer in adolescents and 
young adults and third most common cancer in children, to 
increase long-term complete remission.
That Mitchell Cairo is happy with his new arrangements— 
situated in Dr. Jayabose’s former office in the aging Munger 
Pavilion—is obvious until you get to infrastructure. “Shouldn’t 
you be getting a new office?” he is asked. The question is 
repeated to Dr. Gewitz, who shrugs and mumbles something 
that sounds like trial by Munger, an address of historic repute 
that now includes Dr. Mitchell S. Cairo. n
LEFT PHOTO: If 17-year-old John Capalbo seems a little old to be exam-
ined by Dr. Cairo the pediatrician, consider the odds of a child diagnosed 
with cancer living long enough to outgrow his “baby doctor.”  
RIGHT PHOTO: It takes a dedicated team to keep up with the hectic pace 
of Mitchell S. Cairo, M.D. Clockwise from far left: research assistant profes-
sors Yaya Chu, Ph.D., Yanling Liao, Ph.D., and Aradhana Tiwari, Ph.D.; 
administrative team members Daniel Mitchell and Miguel Muniz; research 
associate Changhong Yin; clinical research team members Karen Wolownik, 
R.N., M.S.N., Deidra Burke and Meghan Metzger; assistant professor of pedi-
atrics Gyeonghun Baeg, Ph.D., lab manager Janet Ayello, M.S., and Dr. Cairo.
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From Any Angle, 
Pediatric Research 
Is a Priority
A significant number of faculty researchers  
in the Department of Pediatrics are conducting 
investigations which they hope will bring about 
advancements in the treatment of children.  
Here are four whose work runs the gamut.
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ALLEN J. DOZOR, M.D.
Professor of Pediatrics
In Dr. Dozor’s world there are two priorities. He is consumed 
with the diagnosis and treatment of asthma, by far the most 
common clinical condition in children. Although the inability to 
catch one’s breath can be terrifying, there are effective medi-
cations and inhalers—rescue and otherwise—that act on the 
immune system to stop the wheezing and coughing that are 
hallmarks of the disease. Of equal concern is his second prior-
ity, cystic fibrosis, but cause and treatment are different for this 
genetic-based ailment that used to guarantee an early death 
sentence for its victims. At Westchester Medical Center he 
directs the Cystic Fibrosis Center, the Pediatric Pulmonary Func-
tion Laboratory and the Children’s Environmental Health Center.
Dr. Dozor attributes the tremendous progress made in treating 
both diseases to the number of multi-center studies that abound 
and are entered by his division, one of the largest of its kind 
with 12 pediatric pulmonologists, 2 allergists and a sleep medi-
cine specialist. “Right now we are participating in eight studies 
and several more are in the hopper,” says Dozor. “Being in 
these studies gives our patients access to new drugs that are 
being designed for specific genetic events that cause cystic 
fibrosis, which has more than 1,500 mutations. It’s a classic 
case of a single gene disease.
“We have received more than $3 million from the American 
Lung Association’s Asthma Clinical Research Centers since its 
inception in 1999. There are 18 centers but only 5 are pediatric, 
including us. I’m very proud that the College is part of these  
trials, which are highly competitive to enter,” he says. He is still 
working on an investigator initiated study that would fit nicely 
with his role as president of the medical staff at Westchester 
Medical Center, and the mandate to expedite and expand  
clinical research at the College.
R
esearch in the United States is a 
carefully guarded enterprise. From 
the initial filing of an application 
with the Food and Drug Administration to 
the final testing for efficacy, the agency is 
empowered to regulate “articles intended  
for use in the diagnosis, cure, mitigation, 
treatment or prevention of disease in man  
or other animals…” The original Food and 
Drug Act of 1906 did not mention children, 
who were expected to be treated the same 
as adults, but at smaller dosages—a pre-
sumption that led to serious, even fatal,  
consequences. Finally, the 1997 Food and 
Drug Modernization Act offered an incentive 
to companies that conducted pediatric  
studies, marking the beginning of a new  
era of research protocols for the treatment  
of children.
And 2011 has been an outstanding year for pediatric research 
at New York Medical College. Following are four faculty mem-
bers who have chosen different paths for their research, all the 
better to cover their areas of interests on subjects who are  
no longer treated as small adults. They are by no means the 
only faculty scientists whose work addresses pediatric issues, 
nor does the Department of Pediatrics hold exclusive rights  
to pediatric research. A further sampling of studies currently 
underway can be found in the box on page 9.
Allen J. Dozor, M.D., participates in multi-center trials of new 
drugs and devices that give his asthma patients a leg up. A 
major cause of hydrocephalus in premature infants has cap-
tured the attention of Govindaiah Vinukonda, M.Sc., Ph.D., 
who is studying hemorrhagic stroke. A dedicated young critical 
care specialist, Simon Li, M.D., worries the methodology used 
in some clinical studies is flawed enough to unfairly influence 
the end results of the trials. And Mahrukh Bamji, M.D., has 
been watching over the HIV and AIDS patients at affiliated 
Metropolitan Hospital Center since they first appeared in the 
mid-1990s.
By Marjorie Roberts
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GOVINDAIAH VINUKONDA, M.SC., PH.D.
Assistant Professor of Pediatrics
Govindaiah Vinukonda, M.Sc., Ph.D., is in search of answers  
to questions that will only leave him with more questions to 
ask—which in a way is the crux of biomedical research. 
“This is my starting point. I’m looking for a breakthrough to  
find something to prevent hydrocephalus in premature infants,” 
he says. It is a worthy cause. The so-called fluid in the brain 
cavities is a medical condition in which there is an abnormal 
accumulation of cerebrospinal fluid (CSF) in the ventricles  
(cavities) of the brain. Hemorrhagic stroke—a spontaneous 
germinal matrix hemorrhage that evolves into intraventricular 
hemorrhage (IVH)—is the most common neurologic complica-
tion of prematurity. Dr. Vinukonda says about 40 percent of the 
infants with moderate-to-severe IVH develop hydrocephalus. 
Little progress has been made up to now in developing an 
appropriate animal model to use in the research, and the total 
absence of human data further restricts the investigation. But the 
scientist expects that to change after this study, which is funded 
by the American Heart Association, is complete. He mentions 
with pride that he is working on developing a promising trans-
lational research model of posthemorrhagic hydrocephalus,  
a condition found in premature infants after brain hemorrhage.
“Since there is a remarkable increase in the survival of prema-
ture infants, the consequences of IVH are a major public health 
concern. The lifetime cost for the management of one child 
with this problem is more than $1 million, and the personal 
tragedy and suffering is enormous,” says Dr. Vinukonda. His 
proposal is designed to develop a mechanism-based thera-
peutic strategy in a preterm animal model, and to treat the  
IVH with decorin. Decorin is a component of the extracellular 
matrix, which neutralizes the brain cytokines (transforming 
growth factor) that appear to play a key role in the development 
of hydrocephalus.
SIMON LI, M.D.
Assistant Professor of Pediatrics
Simon Li is a dedicated physician-researcher. From there on 
out, nothing is ordinary about what he chooses to study. He is 
concerned that the way data is collected may be jeopardizing 
the end results, and he continues to add licenses and certifica-
tions to his CV to ensure that his methodology is as near-perfect 
as he can make it. He is board certified in pediatric critical  
care medicine.
Dr. Li’s combined internal medicine and pediatrics residency at 
Baystate Medical Center/Tufts University School of Medicine 
was followed by a pediatric clinical care fellowship at Yale-New 
Haven Hospital and in pursuit of his Advanced Professional 
M.P.H. from Yale. He continues to work as a pediatric hospital-
ist at Norwalk Hospital in Connecticut.
His research bailiwick is respiratory syncytial virus (RSV), a 
highly contagious virus that causes respiratory infections such 
as bronchiolitis and pneumonia in infants under one year of 
age. In response to a huge influx of pediatric patients with RSV, 
Dr. Li is principal investigator for a prospective cohort study  
to characterize the definition, frequency and duration of RSV-
related apnea events, along with assessing current treatment 
modalities and outcomes. Do these babies need intubation  
or can they be managed without it? He hopes to expand his 
investigation to a multi-center trial.
Another study is tracking the influenza vaccines’ efficacy and 
benefits in children at high risk in a multi-center study. Funding 
originates from the CDC.
“In general, pediatrics has a profound lack of evidence-based 
medicine,” says Dr. Li. “My research is based on good data. 
What I’m trying to do is apply science to the art of medicine.”
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MAHRUKH BAMJI, M.D.
Professor of Clinical Pediatrics
She was there from the beginning. It was the early 1990s, when 25 
percent of children born to women with HIV infection were perinatally 
infected, when there was no definitive test for diagnosis of HIV infec-
tion, when the median age of death in children with HIV infection was 
2 years and when approximately 40 percent of hospital beds in New 
York City were occupied by patients with HIV infection.
Over the years the trajectory of pediatric AIDS in the U.S. has changed 
dramatically. Now the perinatal transmission rate is less than 2 percent, 
children are living longer and are leading otherwise normal lives.
With an annual grant funding of approximately $750,000 each year,  
Dr. Bamji has been involved with several research projects in the field 
of pediatric AIDS. Some of these include a CDC-funded maternal 
infant transmission study, a longitudinal prospective study of HIV-
infected mother/infant pairs that determined the rate of perinatal trans-
mission, the timing of transmission, the factors affecting transmission 
and the natural history of pediatric HIV infection.
She is a participant in several NIH funded clinical trials including a 
landmark trial for treatment of HIV-infected pregnant women to reduce 
perinatal transmission. Well known in the field, Dr. Bamji has a long  
list of publications in peer reviewed journals.
In her role as a project director in Ryan White funding, she is able to 
lead a multidisciplinary team that provides comprehensive medical 
and psychosocial care to HIV infected and affected families.
In addition to her involvement with pediatric AIDS, she is the deputy 
chief of pediatrics at Metropolitan Hospital Center, actively involved 
with teaching residents and medical students. n
As we went to press, there were 
numerous projects devoted to the 
study of pediatric research in 
progress. Though by no means 
an exhaustive list, the studies 
here give a representative 
sampling of clinical and basic 
research supported by the federal 
government, private industry and 
non-profit organ izations. All have 
been highlighted in recent issues 
of Chironian, which are archived 
at http://bit.ly/nPCzwL.
•  Gyeong-Hun Baeg, Ph.D., 
assistant professor of pediatrics. “Identifi-
cation of Compounds That Inhibit STAT 
Activity,” Children’s Cancer Fund.
•  Praveen Ballabh, M.D., 
professor of pediatrics. “White Matter Injury 
in Germinal Matrix Hemorrhage,” National 
Institutes of Health, and “Cytokines and 
Maturation of Oligodendrocytes in a Rabbit 
Model of Intraventricular Hemorrhage,” 
American Heart Association: Founders 
Affiliate.
•  Richard Noto, M.D., 
assistant professor of pediatrics. “The 
Genetics & Neuroendocrinology of Short 
Stature International Study,” Eli Lilly & Co.
•  Mehmet Ozkaynak, M.D., 
professor of pediatrics. “A Comprehensive 
Safety Trial of Chimeric Antibody 14.18 with 
GM-CSF, I1 and Isotretinoin in High-Risk 
Neuroblastoma Patients Following Myelo-
blative Therapy,” and “Children’s Cancer 
Group Program,” National Childhood  
Cancer Foundation (NIH funded).
•  Julian Stewart, M.D., Ph.D., 
professor of pediatrics. “Vascular Dysfunction 
in Chronic Fatigue Syndrome” and “Local 
Vasoconstriction in Postural Tachycardia 
Syndrome,” National Institutes of Health.
•  Oya Tugal, M.D., 
professor of clinical pediatrics. “A Multi-
Center, Open-Label, Non-Controlled Trial  
on Safety & Efficacy of N8 in Previously 
Treated Pediatric Patients with Hemophilia 
A,” Novo Nordisk Pharmaceuticals, Inc.
•  Libor Velisek, M.D., Ph.D., 
professor of cell biology and anatomy. 
“Mechanism of Genetic Seizure Susceptibility 
in Juvenile Myoclonic Epilepsy,” Columbia 
University.
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Waves and Sparks: 
Toward Understanding the 
Complexity of Neurons
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William N. Ross, Ph.D., has developed new imaging 
techniques to help visualize and explain the role of 
calcium in how neurons communicate.
By Cynthia A. Read
M
ention biomedical research, and what’s the first thing 
that comes to mind? Many people will think first of 
studying disease—understanding how it invades and 
develops in the body, and ways to prevent, treat, or cure it. 
Underpinning these critical research challenges, however, is  
the need to understand what is happening at the molecular 
and cellular level, and determining how the body’s natural  
processes can become defective, thus leading to disease.  
This is the goal, indeed the fundamental necessity, of those 
who study the basic sciences.
For one New York Medical College scientist, it all comes  
down to nerve cells—how they operate internally and how they 
communicate with other neurons. William N. Ross, Ph.D., pro-
fessor of physiology, spends his days in search of clues to this 
fundamental cellular process. Using sophisticated, high speed 
optical imaging, Dr. Ross is exploring the exchange of signals 
within the intricate system of pyramidal neurons found in the 
hippocampus, the seahorse-shaped part of the brain involved 
in learning and memory.
Dr. Ross didn’t begin his career probing the mysteries of the 
brain. As an undergraduate he enjoyed biology, but earned his 
B.A. and Ph.D. in physics from Columbia University. Later he 
turned to the study of the brain when talent and good fortune 
enabled him to obtain research and postdoctoral fellowship  
positions, first in physiology and then neurobiology, at Columbia, 
Yale University Medical School, and Harvard Medical School.
GRAY MATTER
“As a particle physicist, I was already comfortable with  
tech nology-based research, so it seemed natural to try to 
exploit this background in a new field,” Dr. Ross explains.  
He quickly became fascinated by the complexity of neurons, 
and his early research focused on the relatively simple, large 
neurons in squid and other marine animals such as barnacles, 
leeches and crabs. But in 1984, after a sabbatical at Hebrew 
University in Jerusalem, he shifted his focus to the mammalian 
brain. Most of his current work is based on neurons in the 
hippo campus of the rat brain, although he is also beginning to 
work with mice—a promising path, since the many available 
mutant mouse models will, he hopes, enable him to further 
refine his understanding of neuronal messaging.
In any area of biomedical research, the available technology 
often controls what you can study. In the 1970s when Dr. Ross 
began his research, microelectrodes were the state of the art in 
stimulating and recording cellular impulses, but they presented 
a challenge. If electrodes can record from only a single place, 
then how does one examine the complexity of action through-
out the cell—in the small, fragile dendrites that carry impulses 
into the nerve cell body and the axons that carry the impulses 
away, as well as within the cell body itself? The answer, it turns 
out, lay in a technique that he pioneered.
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He has observed “calcium waves” 
occurring when a cell is stimulated—
pulsating flashes of light that indicate 
increases in calcium moving through 
the dendrites and into the cell body.
Nerve impulses are far more than simple on-off processes  
that transmit signals from one neuron to the next. They involve 
a cascade of biochemical events, and what happens in one 
part of the cell may not happen in another. To observe how 
neurons integrate and distribute information, Dr. Ross focused 
on exploiting the potential of optical imaging, a technique that 
uses a chemical indicator whose fluorescence is sensitive to 
substances such as calcium. In essence, it is a highly sophisti-
cated version of a scientific process familiar even to elementary 
school children—the litmus test.
Changes in the concentration of calcium reveal several important 
things about neurons. Since calcium concentration increases 
when an impulse occurs, it is a good indirect indicator of an 
electrical impulse in a cell. Calcium also controls the release  
of neurotransmitters, the chemical messengers that neurons 
become to communicate with each other. And in ways that are 
not yet completely understood, calcium controls changes in 
neurons that underlie learning and memory. To observe this 
process using optical imaging, a living neuron in a slice cut 
from the brain is infused with the chemical indicator, and  
the neuron is stimulated with an electrode. The response is 
recorded by a sensitive high speed digital camera, which sig-
nifies the changes in calcium concentration by detecting the 
changes in light intensity. The result is a computer-generated 
film that offers a visual display of these changes—spatially 
throughout the cell and over a period of time.
SEEING THE LIGHT
Dr. Ross was the first to use calcium imaging to study dendrites 
in individual neurons and, as a result, to observe the spatial 
heterogeneity, or unevenly distributed chemical signals, that an 
electrode in the cell body misses. He has observed “calcium 
waves” occurring when a cell is stimulated—pulsating flashes 
of light that indicate increases in calcium moving through the 
dendrites and into the cell body. He is studying whether these 
calcium signals can control the expression of genes. In addition, 
he has identified very localized “calcium sparks” in neurons, 
flashes of activity that occur spontaneously in the brain, even 
when there is no electrical stimulation or activity.
Under his current NIH grant, “Calcium Waves in Pyramidal 
Neurons,” Dr. Ross is looking at the precise localization and 
timing of calcium waves and sparks, as well as their possible 
functions. Some calcium enters a neuron from the outside, 
across the synapse from another neuron, but the calcium in 
sparks and waves is released from internal stores within the 
nerve cell. Calcium waves are found only in the main dendrites 
of pyramidal neurons, but sparks are observed in other den-
drites as well as in axons and the cell body, or soma. What cell 
functions are the waves and sparks controlling? And how are 
they related to the excitability of neurons, whose behavior in 
the circuits of the hippocampus is known to be involved in 
learning and memory?
Helping Dr. Ross to focus on answering these questions are 
the members of his laboratory team: research assistant profes-
sor Nechama Lasser-Ross, Ph.D., his wife, and postdoctoral 
fellows Kenichi Miyazaki, Ph.D., and Changqing Xu, Ph.D.  
Most summers, Dr. Ross continues his research at the Marine 
Biological Laboratory in Woods Hole, Mass., where he notes 
that many fruitful collaborations and research projects have 
been generated.
In addition to his research, Dr. Ross lectures medical students 
in physiology and neuroscience, and teaches an advanced 
neuroscience course with other faculty in the School of Medicine. 
Throughout his 30-plus years at the College, Dr. Ross says he 
has enjoyed the stable environment, the collegiality, and the 
support of his department for his research.
PYRAMIDAL NEURON: In the image above, taken with a 2-photon microscope, a pyramidal neuron in the hippocampus glows with a fluorescent dye that 
is sensitive to changes in calcium concentration. A series of images taken at one-micron intervals were stacked and flattened to give the resulting image. 
The tiny stubs protruding from the branches are dendritic spines, sites of synaptic contacts. (Image courtesy of Dr. Ross)
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NEURONS AT WORK
“Bill Ross is not only an asset to New York Medical College, he’s also a leading authority known world-
wide for his studies of calcium movement within neurons,” says Department Chair Thomas H. Hintze, 
Ph.D. ’80. “He has published in the best journals, including the Proceedings of the National Academy of 
Sciences (USA) and Nature, and he was invited to write a review article on calcium movement in neurons 
for the Annual Review of Physiology. It’s not unusual to see him hosting a scientist from another institution 
who has come seeking his advice—not just about the science but also the techniques that Dr. Ross has 
perfected. He has made a significant impact on our understanding of how neurons work, and the College 
is fortunate to have him on the faculty.”
Francis L. Belloni, Ph.D., dean of the Graduate School of Basic Medical Sciences, concurs: “Bill has  
been a valuable contributor to the College’s strong international reputation in biomedical research. His 
work is both scientifically important and, owing to his computer-assisted visualization methods, it’s also 
aesthetically stimulating. He is a key member of both the physiology department and the neuroscience 
core group, which spans several departments.”
In focusing on neurons at the cellular level, Dr. Ross sees his work as a contribution to the larger story of 
understanding the brain, from the most basic—the molecule—to what some call brain science’s ultimate 
question, consciousness. He expects those calcium waves and sparks to hold an important clue. n
Helping William Ross, Ph.D., to maintain his intense focus on his neuroscience research and teaching are the members of his 
laboratory team. They might even be called the “brain trust.” (From left): postdoctoral fellow Kenichi Miyazaki, Ph.D., assistant 
professor Nechama Lasser-Ross, Ph.D., and postdoctoral fellow Changqing Xu, Ph.D.
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By Andrea Kott, M.P.H.
Gladys M. Ayala, M.D., M.P.H.,
     Has Her Finger on
 the Pulse of
     Student Life
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H er business card makes it clear: Gladys M. Ayala, M.D., M.P.H., Senior Associate 
Dean for Student Affairs, Dean of 
Students and Associate Professor of 
Clinical Medicine, is a highly accom-
plished woman. What the card does  
not reveal, however, is just how sweep-
ing her role at the College is—overseeing 
the educational life cycle of every medi-
cal student, from the moment they arrive 
on campus until the day they graduate.
It is a formidable job and Dr. Ayala is 
quick to credit the Office of Student 
Affairs for carrying it out. “From receiving 
them [students] at the admissions office 
to making sure they are certified and 
ready to graduate—anything that hap-
pens in between will usually be handled 
through this office,” she says.
Dr. Ayala is a compact, fast-talking 
woman with a penchant for speaking in 
the third person, even when she is the 
topic of conversation. “I’m not much for 
talking about myself,” she says with an 
awkward smile.
In fact, Gladys Ayala is the engine that 
drives the Office of Student Affairs. 
Under her leadership, the academic, 
extracurricular, personal and professional 
details of every medical student’s life are 
guided and coordinated—from academic 
advising to career planning, from housing 
and financial aid to health and wellness, 
from diversity issues to study abroad, 
and from internships to fellowships to 
Match Day. “We make sure no student 
falls through the cracks,” she says.
In her corner office, Dr. Ayala sits at a 
massive desk, with an equally large work 
table behind her. Stacks of files and 
papers cover every surface. Two com-
puter monitors stand side by side. A bag 
of almonds nearby suggests that break-
ing for lunch, at least today, probably 
won’t happen.
It is an especially busy time. The aca-
demic year has just begun and about 
half of the school’s 800 medical students 
have arrived on campus—but all need 
attention. First-years need guidance 
choosing classes and electives and 
thinking about a potential summer 
research fellowship. Second-years need 
help identifying faculty members to men-
tor them. Third-years need help with 
career planning and securing letters of 
recommendation for residency applica-
tions. Fourth-years need help applying to 
residency programs and making sure 
they have all the credits they need to 
graduate.
“Each class year has its different compo-
nents and needs,” Dr. Ayala says, patting 
a pile of medical student evaluations 
awaiting her approval. She will not simply 
sign these in rubber-stamp mode. She 
will familiarize herself with the medical 
school careers of each of the 200 stu-
dents they represent, who are scheduled 
to graduate in May. The material covers 
classes they have taken, clubs they have 
joined, committees they have served, 
research they have published, internships 
they have done, scholarships they have 
won, careers they are pursuing and  
residencies to which they have applied. 
She has just a few weeks to read them 
all. And this is only part of her job, she 
says, using a grammatical metaphor to 
describe the nonstop pace at which she 
and her colleagues work. “We only have 
run-on sentences. There are no periods.”
Some might find such constant and 
demanding work overwhelming, but  
Dr. Ayala is a devout multi-tasker whose 
personal mission is nothing less than 
assuring the well-being of every student.
 She works endlessly, much of it behind the 
scenes, to advance student life in general  
at New York Medical College and to help 
individual students in need. She sees herself 
as having 800-plus students in her charge.
“
”
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“The task is daunting, but she meets it head on with enthusiasm and focus,” says 
her immediate supervisor Paul M. Wallach, M.D., vice dean of undergraduate medical 
education, who has worked with Dr. Ayala for the past two years. “She works end-
lessly, much of it behind the scenes, to advance student life in general at New York 
Medical College and to help individual students in need. She sees herself as having 
800-plus students in her charge.”
What makes Dr. Ayala especially well-suited to the particular challenges of her post 
is having endured the trials of her own medical education and training. “I’ve been 
there and I’ve lived through them,” she says.
At one time, all Dr. Ayala ever wanted was to become a primary care physician. “I can’t 
remember anything else that I wanted to do,” she says. She grew up in Brooklyn 
during the 1960s and 1970s, the youngest child of Puerto Rican immigrant parents, 
neither of whom finished high school or spoke English when they arrived in the 
United States.
“They had to learn English at a time when language support services were not avail-
able,” Dr. Ayala says. “That’s being a pioneering spirit.”
Dr. Ayala knows plenty about pioneering: She went to the Mount Sinai School of 
Medicine, when few women and even fewer women of color attended medical 
school. Yet, she notes, “I was going to medical school because I was qualified, not 
because of my ethnic or racial background.”
Her qualifications started with a rigorous 
parochial school education. She earned  
her bachelor’s degree at Long Island 
University in Brooklyn, graduating in 1982  
with the Pre-medical Science Award and 
recognition for outstanding services in  
the biology department. Immediately 
afterward, she began medical school,  
followed by internships and residency  
in internal and emergency medicine at  
St. Luke’s/Roosevelt Hospital Center  
in Manhattan.
Few role models propelled Dr. Ayala 
through medical school. TV characters 
like Dr. Kildare and Marcus Welby, M.D. 
offered some inspiration, as did her per-
sonal physician, a woman. But the real 
calling was her deep desire to be able to 
care for anybody who walked through 
her door. She saw illness as an equalizer, 
and the practice of medicine as a way of 
focusing on people’s shared humanity, 
instead of their differences.
With her two closest Student Affairs colleagues, 
associate deans Elliot N. Perla, M.D. ’74 (left), and 
Christopher Cimino, M.D., Dr. Ayala shares a love 
of students and a deep understanding of the 
many challenges they will face in their careers.
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“Ours is a racially driven society and I 
saw medicine as a way of bridging that,”  
Dr. Ayala says. “Whatever patient walks 
through the door is my patient, my focus. 
Once a patient is sick, nothing else 
matters.”
Before launching her career as a primary 
care physician, Dr. Ayala took off some 
time to volunteer with the International 
Focolare Movement, and ecclesiastical 
Catholic society. For two years she worked 
and volunteered as a medical consultant, 
and also pursued religious studies in Italy 
and Switzerland. In 1992, she began 
working at College-affiliated Metropolitan 
Hospital Center in Manhattan.
Always seeking new challenges, she 
became an assistant program director in 
residency training one year after joining 
the staff of Metropolitan as assistant  
professor of medicine. Two years later, 
she became co-director of medicine-
pediatrics residency training and deputy 
chief of medicine for graduate medical 
education. Along the way she squeezed 
in a promotion to associate professor 
and earned a master of public health 
degree from Columbia University. Later 
she became an adjunct associate pro-
fessor of clinical public health.
“I think it improved everything I did,” she 
says of her M.P.H. “It gave me more 
credibility.”
For Dr. Ayala, pursuing new opportunities 
has been a way to enhance her experi-
ence and skills, and bring more to the 
table. “As I was exposed to more and 
more things, I found a lot that I was inter-
ested in doing,” she says.
With each advancement, she has become 
more visible and sought after as a practi-
tioner, a clinical teacher, a medical school 
professor, faculty committee member 
and a leader. In 1997, Dr. Ayala was 
appointed associate dean for student 
and minority affairs. Until just a few years 
ago, she still was dedicating 20 percent of 
her time to clinical work, which included 
supervising residents in clinic. But, she 
says, “There comes a time when balls 
start dropping.”
In 2008, after accepting her current 
appointment, she made a complete transi-
tion from a clinical to an administrative life. 
“We’ve moved from a patient-centered 
care model to a student-centered care 
model,” she says, using her signature 
style of the “royal we.” She confesses to 
missing clinical practice and therefore 
continues to teach Foundations of Clinical 
Medicine I and II.
Carrying such a full load can be a tre-
mendous motivator, and Dr. Ayala would 
not want it any other way.
“I’m the type who looks at opportunities 
to see how they improve what I’m cur-
rently doing and how they could lead to 
something else,” she says. “One has to 
be open to possibilities and never close 
oneself off.” n
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A fter a rigorous first year of medi-cal school, Monique Hall spent the summer learning even more.
“I wanted my summer break to be a 
rewarding experience where I could be 
exposed to clinical research and be of 
benefit to the community,” says Hall, who 
helped hypertensive patients manage 
their blood pressure at a community 
health center in Peekskill as part of a 
four-week service learning preceptorship 
in Family and Community Medicine.
“My family has been plagued with hyper-
tension and strokes for generations,” she 
says, “so it seemed only natural that the 
project sparked my interest.”
SHATTERING MYTHS
Initially, Hall was skeptical about the effi-
cacy of the community health center, 
part of the Hudson River Health Care 
System (HRHC), which serves 42,000 
patients a year, many of whom are 
migrant workers and other vulnerable 
populations. “I thought the center would 
be dismal, poorly kept, and overflowing 
with patients,” she recalls. “I thought the 
staff would be tired, overworked, under-
paid and irritable. I expected patients to 
receive minimum medical treatment and 
have few resources.”
But she says the moment she actually 
set foot in the clinic, she saw how wrong 
these assumptions had been. The 
cheerful, compassionate staff, the well-lit 
waiting room stocked with reading mate-
rial, and the flat-screen TV showing a 
program on diabetes shattered the stereo-
type she had held.
LESSONS COME TO LIFE
In the classroom, all medical students 
learn about the biopsychosocial model  
of treating patients, which considers  
science, psychology and social interac-
tions. “I knew every patient was different, 
and should be treated first as an indi-
vidual instead of a ‘disease state,’ says 
Hall, “but it was still hard to determine 
exactly how their lives were affecting 
their treatment.”
At the health center, Hall saw the model 
come to life. She observed as attending 
physician Jaime Khemraj, M.D., reviewed 
each patient’s chart and medical history 
before entering the examining room. She 
also noticed how the doctor took differ-
ent tactics with each patient, reading 
subtle cues in facial expressions or body 
language. “With an elderly hypertensive  
“ Service learning” 
places classroom lessons under real-world pressures
What drives students to reach out to the community at a time when they’re 
immersed in their studies? Often it’s about exploring today’s landscape of 
medicine—and putting to the test what they think they know.
By Melissa F. Pheterson
Monique Hall’s preconceived notions about working at a community health center were over-
turned by her positive experiences there.
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female who was non-compliant on taking 
her medication, she was stern,” Hall 
recalls. “With a newly sexually-active 
teenage female who was poorly advised 
on the effects of birth control, Dr. Khemraj 
became a teacher. With a young woman 
who had irregular menstrual cycles, but 
was only there for a physical to accom-
pany a job application, Dr. Khemraj was 
more cautious about suggesting that  
the patient start on birth control pills to 
regulate her periods,” says Hall. “In this 
situation, she felt that pushing the patient 
might have had adverse results.”
“When I finally decide which specialty I 
would like to pursue and in what com-
munity setting,” Hall says, “I will think 
back to my time at HRHC.”
NEW HORIZONS,  
NEW PERSPECTIVES
Like Hall, second-year Jawad Rashid 
decided to take part in the Department 
of Family and Community Medicine’s first 
service learning summer preceptorship, 
an innovative new program aimed at 
improving opportunities for and raising 
the visibility of underrepresented minority 
students in the health professions, over-
seen by Montgomery Douglas, M.D., 
chairman of the Department of Family 
and Community Medicine.
When it came time to choose a summer 
preceptorship, Rashid decided on public 
health research. He spent four weeks at 
the Westchester County Department of 
Health in New Rochelle, harvesting and 
killing the mosquitoes that cause West 
Nile virus. Through a program estab-
lished in response to the initial outbreak 
of West Nile in 1999, Rashid and his 
cohorts used nets to capture a represen-
tative mosquito population from parts of 
Westchester county that were deemed 
as high risk, sending samples to the 
state lab in Albany to be tested. Positive 
samples are reported to the state, county 
and the CDC for tracking the number of 
positives and incidence of human infec-
tions for its yearly report.
“Initially, it was mostly curiosity about 
how the Department of Health func-
tioned,” says Rashid of his choice. But 
now he appreciates how the experience 
broadened his perspective of medicine 
and health.
“In class, our focus is mostly on the 
human body, whereas the impact of 
environment and society is not often 
explored,” he says. “When I took Micro-
biology this year, my understanding of 
pathogens was made richer by the expe-
rience of how a local government often 
has to get involved to reduce the inci-
dence of infectious diseases.”
Rashid’s experience left him with both a 
deeper appreciation of the work of the 
Department of Health and a “newfound 
interest in public health, a focus on the 
bigger picture”—to the point where he’s 
considering a Master’s in Public Health 
and perhaps a position at the CDC or 
the FDA.
ENRICHING THE ENVIRONMENT
Dr. Douglas coined the phrase “service 
learning” opportunities to describe the 
preceptorships whose broader objec-
tives take them out of the realm of “pure 
volunteerism.”
“Because it’s hands-on, and because 
people remember more by doing some-
thing than by hearing about it, the reten-
tion of the material is much higher,” he 
says. “And I’m sure the students will tell 
you, it’s so much more fun than sitting in 
a classroom. But when they return to the 
classroom and lab, they bring so much 
back with them that it enriches the whole 
learning environment. Moreover, going 
into the real world and seeing what hap-
pens in the clinic or at the Department  
of Health helps students get a peek at 
their future and allows them to hone their 
career goals.”
Dr. Douglas is working with faculty  
members and the students themselves 
to develop a menu of service-learning 
opportunities. Ultimately, he says he will 
recommend that every student at New 
York Medical College participate in some 
form of service learning. The initiative  
will include expanding the program at  
La Casita de la Salud, the student clinic 
established in East Harlem in 2005 by a 
group of medical students with the sup-
port and blessing of Ralph A. O’Connell, 
M.D., provost and dean of the School of 
Medicine.
Jawad Rashid conducted public health research during his preceptorship—now an M.P.H. is 
likely to be in his future.
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THE MED SCHOOL PARADIGM
In addition to their academic workload, 
second-year medical students Breige 
O’Donnell and Jesse Roberts are the 
volunteer administrative director and clin-
ical director, respectively, of La Casita de 
la Salud, a clinic in East Harlem coordi-
nated by first- and second-year students 
and supervised by volunteer physicians. 
O’Donnell and Roberts oversee 72 vol-
unteers and an executive board of 20. 
They’re at the clinic nearly every Saturday, 
with on-campus meetings several times 
a week.
“When I applied to med school, a student 
clinic was a feature I was looking for,” says 
O’Donnell. “I wanted to take my ideas to 
the next level, to have a bigger impact.”
While a grad student at Tufts University 
in Boston, Roberts had worked at a  
student clinic to explore how lecture-hall 
principles fare in the real world. “I knew  
it would be a great way to see first hand 
how clinical medical care impacts a 
community with limited access to care,” 
he says. “At La Casita, we try to dig into 
those social issues, ones that go beyond 
clinical care.” The East Harlem patients—
many struggling with poverty, illiteracy 
and increased risk for chronic disease—
can provide a litmus test of “how our 
ideas might conflict with reality,” he 
explains.
“This reverses the paradigm of medical 
school,” he points out. “We have the 
privilege of learning from our patients, 
not just treating them. That gets to the 
heart of why I wanted to be involved.”
O’Donnell adds, “We’re so focused on 
learning from textbooks, but it’s impor-
tant to look at the community you serve 
and apply, or even expand, your source 
of knowledge.”
Teams of medical students and at least 
one supervising attending physician take 
patient histories, perform physical exams, 
make diagnoses and create treatment 
plans. What makes the experience value-
added for the students is the opportunity 
to examine the barriers patients face in 
seeking and receiving care—“the steps 
in the process that turn patients away,” 
says Roberts. Among those barriers are 
discrimination or intimidation, subtle or 
not, patients’ long work hours and ineligi-
bility for insurance.
To surmount these obstacles, the staff of 
La Casita works to shape the clinic into 
an “outreach mechanism,” as Roberts 
describes it, “where we lower barriers to 
care, offer individualized assistance in 
negotiating the health care system, and 
fold patients into the long-term health-
care relationship that’s right for them.”
The clinic has helped Roberts hone his 
own career focus. He plans to pursue  
a position in health-care management, 
coordinating services and ideas among 
different groups with distinctive perspec-
tives of medicine.
But La Casita has also inspired Roberts 
and O’Donnell to draw together fellow 
students in a common objective: enhanc-
ing their studies while helping the com-
munity. To that end, the two are helping 
to develop a curriculum for all students 
who choose to pursue service learning at 
the clinic. They credit the faculty of Metro-
politan Hospital, along with Dr. Douglas 
and Gladys M. Ayala, M.D., M.P.H., senior 
associate dean for student affairs, for 
their crucial support.
“We’re full-time students,” Roberts says. 
“We don’t go from idea to implementa-
tion in a month. But our strength lies in 
harnessing the manpower of the entire 
first-year class.” n
Jesse Roberts (left) and Breige O’Donnell volunteer portions of their scarce free time as the student 
directors of La Casita de la Salud, a clinic in East Harlem where medical students confront the cultural 
obstacles that can hinder access to affordable health care.
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A s a nationally known child abuse expert and one of the nation’s first board-certified child abuse pediatricians, Jennifer Canter, M.D., M.P.H., is well acquainted with 
the deep complexity of family life. Dr. Canter directs the Child 
Abuse Pediatrics programs at New York Medical College, Maria 
Fareri Children’s Hospital at Westchester Medical Center, and 
the Westchester Institute for Human Development (WIHD). In 
that role, she evaluates more than 600 children each year for 
signs of maltreatment, including physical and sexual abuse, 
neglect and unexpected fatalities.
But it was becoming a parent herself that really helped  
Dr. Canter more fully understand the myriad complexities and 
challenges of parenting, and aided in her understanding that 
some suspicious injuries may not be abuse-related. (See side-
bar on page 23, “Abuse—or Not?”)
“When I began this work I thought it would be interesting  
and diverse and I enjoyed the fast pace,” says Dr. Canter, an 
assistant professor of pediatrics and the mother of two sets of 
twins under the age of 10. “But since becoming a mother I can 
understand parenting and children from an enhanced perspec-
tive. I have more insight into the stressors of parenting, and I 
recognize the need to have an open mind. For example, I was 
trained in med school that certain fractures couldn’t happen in 
certain ways. But sometimes they can. You really have to listen 
carefully to what parents are telling you.”
T R A I N I N G  P E D I A T R I C I A N S  T O  
Recognize Child Abuse
A new nationally accredited fellowship program—led by a doctor who’s 
also a mom—aims to protect the region’s most vulnerable kids.
By Nelly Edmondson Gupta
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Good listening is just one of many skills 
child abuse pediatricians need. In order 
to become board certified, medical 
school graduates must complete a resi-
dency in general pediatrics, followed by 
a rigorous three-year fellowship. In the 
course of training, they learn how to 
examine children in a sensitive manner 
and how to conduct a comprehensive 
assessment for all types of abuse. 
Fellows also must become expert in the 
legal issues that pertain to cases, and 
may be called upon to testify in court.
The field of child abuse pediatrics got its 
start in 1962, when the Journal of the 
American Medical Association (JAMA) 
published a groundbreaking article, “The 
Battered Child Syndrome.” Though it 
focused attention on the issue of child 
maltreatment, the subspecialty did not 
become accredited until 2008. New York 
Medical College currently sponsors one 
of only 20 child abuse pediatrics fellow-
ship programs in the country.
“Child abuse is a regrettably common 
public health problem that society has 
not dealt with adequately, partly due to a 
lack of trained medical personnel,” says 
Richard G. McCarrick, M.D., vice dean 
for graduate medical education. “It’s an 
extremely valuable program, and I am 
very proud that we are among the few 
academic medical centers to offer it.”
A DAY IN THE LIFE
Pediatricians Wan-Keung Chen, M.D., 
and Vinod Rao, M.D., are currently 
enrolled in the fellowship program.  
Dr. Chen is in his second year; Dr. Rao  
is in his first.
Dr. Chen grew up in Maryland and knew 
early on that he wanted a career in med-
icine. But he didn’t settle on child abuse 
pediatrics until he did a two-week rota-
tion at an advocacy center in Queens, 
N.Y. “Child abuse pediatrics isn’t really 
well known,” he points out. “It’s a very 
small field, and it doesn’t get that much 
exposure.”
Dr. Rao, born and raised near Akron, 
Ohio, knew he wanted to work in pediat-
rics even before starting medical school. 
But he, too, decided to focus on child 
abuse during his residency after realizing 
that the family dynamics and interper-
sonal aspects of abuse cases fascinated 
him. He also liked being part of a team 
that requires careful observation and 
skillful listening. “Some cases are very 
straightforward, others are more com-
plex,” he says. “Those are the ones that 
interest me the most.”
When the two doctors arrive each morn-
ing at the Children’s Advocacy Center 
(CAC), located in the WIHD building on 
the campus it shares with the College, 
they often don’t know what the day will 
bring. Although the center is officially 
open from 9 to 5, hours often change 
depending on the calls that come in 
from the State Central Register of Child 
Abuse and Maltreatment. “It’s very dif-
ferent from an ordinary medical clinic 
where you have patients scheduled 
weeks, even months, in advance,” says 
Dr. Chen. The doctors must be flexible, 
sometimes working late to accommodate 
the needs of their patients. “Five patients 
may not sound like very many,” he says. 
“But that can include five different fami-
lies and five separate multi-disciplinary 
teams that may include investigators, 
attorneys and law enforcement officials.”
In addition to their clinical work, which 
takes place at the CAC or the hospital, 
the fellows conduct research, and pro-
vide education for medical students and 
residents. Dr. Chen says this gives stu-
dents who are considering careers as 
general pediatricians an overview of the 
“ Child abuse is a 
regrettably common 
public health problem 
that society has not 
dealt with adequately, 
partly due to a lack  
of trained medical 
personnel.”
—Richard G. McCarrick, M.D.
Teaching the complex skill set required of a pediatrician trained to recognize and treat child abuse can 
be stressful and disturbing, but Jennifer Canter, M.D., M.P.H., is up to the challenge. She consults 
often with her two fellows, Vinod Rao, M.D., left, and Wan-Keung Chen. M.D.
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According to Jennifer Canter, M.D., M.P.H., 
one of the most important skills child abuse 
pediatricians learn is how to distinguish abuse 
from injuries that mimic abuse. As the following 
incidents suggest, this requires patience, per-
sistence and trusting one’s gut instincts.
Dr. Canter described two examples with 
babies she has evaluated over the past 10 
years. The first was a three-month-old infant 
with a bruise on its head. “There was no real 
reason why the baby should have that bruise. 
The situation was not consistent with the 
child’s developmental level,” says Dr. Canter. 
“But when I talked to Mom alone and asked, 
‘Do you feel okay going home?’ she disclosed 
there had been domestic violence—and that 
father had thrown the baby against the wall.”
In the second case, after examining a baby 
with a skull fracture and talking with the family 
and other members of her team, Dr. Canter 
concluded that the injury was an accident. The 
new mother had placed the baby on a chang-
ing table, and when she turned around to get 
a wipe, the child fell to the floor. “These are 
things that can happen to any parent,” says  
Dr. Canter, “and there are simple things par-
ents can do to prevent them.”
Dr. Canter stresses that her role is not to pass 
judgment on families, and she trains the fellows 
the same way. “I make it clear that the child 
abuse pediatrician’s role is not to decide who 
gets prosecuted or who the child goes home 
with,” she says. “Rather, it is to work with the 
family to understand what happened, to evalu-
ate the patient and provide accurate medical 
information to the team.”
Dr. Canter says there is no easy solution to the 
problem of child maltreatment: “I have patients 
who were teenagers when I started 10 years 
ago, and sometimes their own children come in 
to be evaluated for suspected abuse. It makes 
me sad. It also tells me that I have to accept 
that we are never going to solve the problem 
of child abuse 100 percent. All we can do is 
use each day to do the best we can.”
—N. Gupta
ABUSE—OR NOT?
subject, so that when they encounter suspicious injuries later 
on, they will know when to ask themselves, Is this something  
I should be concerned about? Does it raise enough suspicion 
to get someone else involved?
For his research project, Dr. Chen is developing a questionnaire 
for physicians focusing on how they assess injuries in infants 
less than one month of age to determine whether those injuries 
are the result of abuse, accidents, or birth-related trauma.  
Dr. Rao has yet to decide between a study of depression in 
premature infants and a project that will screen children for 
head trauma.
After completing their fellowships, both men hope to work at 
children’s advocacy organizations that are affiliated with hospi-
tals or academic centers, perhaps even establishing additional 
child abuse pediatrics fellowship programs.
Dr. Chen and Dr. Rao agree that dealing with the deaths of 
children is the most challenging and disturbing part of their 
training. They, along with Dr. Canter, are involved in all unex-
pected child fatality cases that occur in Westchester County. 
This entails meeting with other team members to determine 
exactly what happened to cause a child’s death.
ON CLOSER INSPECTION
When a child dies unexpectedly, the Westchester County Child 
Fatality Review Team meets to evaluate the factors that may 
have contributed to the child’s death to see if there are any 
injury-prevention lessons to be learned. The reviewers include 
members of the pediatric child abuse team, the medical exam-
iner, the district attorney and Child Protective Services.
Two of the most important public education initiatives that have 
come out of this process include one on safe sleep and one  
on Shaken Baby Syndrome (SBS). “We have evaluated fatalities 
of children who die in what are considered to be unsafe sleep  
situations,” says Dr. Canter. She and her colleagues explain to 
families that safe sleep includes putting a baby flat on its back 
on a firm mattress in a bed designed for sleep—not a couch 
or playpen—that is free of pillows and toys.
She is also one of the principal investigators in the New York 
State Shaken Baby Syndrome program, a statewide initiative 
that aims to educate parents about SBS shortly after a baby is 
born. The program teaches parents to heed the warning signs 
that they are likely to become abusive, and to take action to 
keep from harming their children. In a study led by her col-
league Robin L. Altman, M.D., associate professor of pediat-
rics, Dr. Canter and fellow investigators from the Department of 
Pediatrics found that the initial program covering the Hudson 
Valley led to a 75 percent reduction in the frequency of shaking 
injuries. Their study was published in the November 2011 
Pediatrics. n
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GR ADUATE STUDENTS 
Explain It All for You
Novel Intervention 
Strategies in Breast Cancer 
Cellular Crosstalk
By Andrea George
 B reast cancer is one of the leading causes of death among women, and more than 200,000 new diagnoses will be made this year in the U.S. alone. Playing a critical 
role in cancer development is the breast tumor microenviron-
ment, or TME. The breast cancer TME is composed of cancer 
cells, infiltrating endothelial cells that help form tumor blood 
vessels, and immunomodulatory cells like macrophages that 
generate an inflammatory microenvironment. Each of these cell 
types plays a role in tumor growth and metastasis, and cancer 
research has begun to focus on disrupting this interplay, or 
“crosstalk,” of different cells in development of novel therapeu-
tic strategies.
Rapid tumor growth relies on formation of tumor blood vessels 
that provide the cancer cells with nutritional support. The 
tumors recruit cells from the bone marrow, which help form 
these vessels and feed the tumor. These cells are known as 
bone marrow-derived endothelial progenitor cells (BM-EPCs). 
Our novel finding in our lab is that circulating hormones, like 
estrogen, help mobilize these bone marrow cells and direct 
them to the tumor. Here these cells secrete factors that aid in 
new blood vessel formation, or neovasculogenesis. However, 
the cellular mechanism by which estrogen is able to participate 
in neovasculogenesis remains unclear.
But other cells are found in the breast TME as well. Macrophages 
and endothelial cells create an inflammatory tumor environment, 
and this inflammation helps the tumor cells undergo a morpho-
logical change known as epithelial to mesenchymal transition 
(EMT). EMT makes the tumor cells more aggressive and allows 
cancer cells to metastasize from the primary breast tissue into 
the circulation and other organs. Our goal is to determine how 
the various cells in the breast TME promote this morphological 
change, and to develop new strategies aimed at diminishing 
breast cancer metastasis.
We are conducting studies to determine the precise interaction 
of tumor associated macrophages (TAMs) with breast cancer 
cells. We hypothesize that by decreasing the interaction of 
TAMs with cancer cells, we will diminish inflammation and pre-
vent the cancer cells from metastasizing. By focusing on both 
development of tumor blood vessels and inflammation, we 
hope to uncover new targets for breast cancer therapeutic 
strategies and gain a better understanding of cancer cell 
metastasis. n
➤ ANDREA GEORGE
Andrea George, originally from Elmira, N.Y., is a Ph.D. candidate working in the laboratory of Raj K. Tiwari, Ph.D., professor and graduate program director 
in the Department of Microbiology and Immunology. Prior to entering the college’s Integrated Ph.D. Program in 2007, Ms. George earned a B.A. in biology 
from Alfred University. She then joined the laboratory of Bud Tennant, D.V.M., at Cornell University in the Department of Comparative Medicine where she 
studied Hepatitis B infection using a woodchuck animal model. It was during her work there that she became interested in immunology with a specific 
focus on tumor immunology. Ms. George intends to pursue an academic career in cancer research, with a specific focus on the immunological response.
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20-HETE: A Key Player in 
Hypertension and Vascular 
Inflammation
By Yan Ding
T he main focus of my work is on 20-hydroxyeicosatetrae-noic acid (20-HETE)-mediated vascular inflammation and remodeling in hypertension. 20-HETE is a 20-carbon 
hydroxylated fatty acid found in the microcirculation, where it 
participates in the regulation of vascular tone and contributes 
to vasoconstriction, proliferation of vascular smooth muscle 
cells and growth of new blood vessels from pre-existing ves-
sels. Studies in the lab identified 20-HETE as the mediator  
of androgen-induced hypertension and vascular dysfunction. 
Inhibition of 20-HETE’s production prevents the ability of 
androgen to induce hypertension.
Epidemiological, clinical, and experimental studies have impli-
cated androgen as an important determinant of gender-specific 
differences in arterial blood pressure. Men younger than 60 
years of age have a higher systolic blood pressure than pre-
menopausal women of the same age. In addition to loss of 
estrogen, androgen levels are often elevated in postmeno-
pausal women. In fact, postmenopausal women have a risk  
in developing high blood pressure that is equal to that of or 
greater than men.
Hypertension is a major risk factor for cardiovascular compli-
cations including myocardial infarction, atherosclerosis and 
stroke. Changes in vascular function and structure including 
endothelial dysfunction, vascular inflammation and remodeling 
are the consequence of persistent high blood pressure. 20-HETE 
has been shown to affect vascular function.
Our laboratory is currently investigating the mechanism under-
lying 20-HETE-mediated vascular inflammation and remodeling 
in androgen-induced hypertension. Recent studies have dem-
onstrated that androgen upregulates 20-HETE synthesis in the 
vasculature and suggest that the CYP4A-derived 20-HETE is a 
key mediator of androgen-induced vascular dysfunction and 
hypertension.
In other studies we have shown that 20-HETE mediates  
androgen-induced hypertension in rats and mice and that 
androgen increased the rate of vascular synthesis and actions 
of 20-HETE. In addition, androgen-induced 20-HETE-mediated 
hypertension is associated with increases in vascular expression 
of inflammatory factors, production of superoxide and infiltration 
of inflammatory cells within the vascular wall. We also have 
demonstrated that androgen-induced hypertension is accom-
panied by remodeling of the renal microvasculature and that 
this process is dependent on the synthesis and actions of 
20-HETE.
We are preparing to explore specific pro-inflammatory and  
pro-hypertensive factors underlying vascular remodeling in this 
androgen-induced hypertensive model and their relationships 
with 20-HETE. In perspective, this study will suggest that 
20-HETE can be a potential target for vascular dysfunction  
and remodeling that take place in hypertension. Inhibition of 
20-HETE–mediated signaling in the vasculature may be a novel 
therapeutic approach to treating hypertension and its cardio-
vascular complications. n
➤ YAN DING
Yan Ding, originally from China, is a Ph.D. student in the laboratory of Michal L. Schwartzman, Ph.D., professor and chair of pharmacology. After earning 
her bachelor’s degree from Huazhong University of Science and Technology in 2009, she joined the Integrated Ph.D. Program in the Graduate School of 
Basic Medical Sciences to pursue her interest in researching cardiovascular diseases with Dr. Schwartzman. Ms. Ding’s future research will further explore 
the role of the arachidonic acid metabolite, 20-HETE, in vascular remodeling and inflammation in hypertension. She hopes to add noteworthy scientific 
achievements to her CV by the time she finishes her Ph.D., and plans to continue this avenue of research throughout her career.
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PERFECTING BONE 
MARROW AND STEM CELL 
TRANSPLANTATION TO 
SAVE LIVES
Ruthee-Lu Bayer, M.D. ’92
By Cynthia A. Read
Physicians and researchers always aim for perfection, although it 
may often seem distant or even impossible. Yet Ruthee-Lu 
Bayer, M.D. ’92, believes even that lofty goal is attainable in treat-
ing people with leukemia, lymphoma and other life-threatening 
diseases who need a bone marrow or stem cell transplant.
Call her a bold dreamer, but striving for hard-to-reach goals is a 
touchstone in Bayer’s life. Her journey to her present position as 
chief of the Don Monti Bone Marrow and Stem Cell Transplanta-
tion Unit in the Monter Cancer Center at North Shore LIJ Health 
System—and her connection to New York Medical College—
began in childhood. Because of a congenital defect, she had  
22 corrective orthopedic surgeries while growing up. Her skilled 
and beloved surgeon, who eventually became her mentor, was 
Arthur Michele, M.D. ’35, who was professor and chairman of 
the Department of Orthopaedic Surgery at Flower Fifth Avenue 
Hospital when it was still part of the College.
Michele encouraged Bayer’s interest in medicine and urged her 
to major in engineering as an undergraduate, which he believed 
would provide a good basis for understanding the human body. 
Inspired by Michele, Bayer received her B.S. from Columbia 
University School of Engineering and Applied Science in 1988 
and her M.D. from the College in 1992. At first she had wanted 
to follow in his footsteps by becoming an orthopedic surgeon, 
but realized she didn’t have the physical stamina and ability that 
specialty requires. Her grandmother’s death from breast cancer 
sparked her interest in oncology and in bone marrow and stem 
cell transplantation.
Chemotherapy and radiation are used to treat cancer because 
cancer cells divide more rapidly than most healthy cells. But 
bone marrow cells also divide frequently and can be damaged 
or destroyed by the treatment, leaving a patient without healthy 
bone marrow to make the blood cells necessary to carry oxy-
gen, fight infection and prevent bleeding. Sometimes healthy 
blood-forming stem cells from bone marrow (or from the blood-
stream or umbilical cord blood) are transplanted into cancer  
patients to restore their bodies’ ability to produce new blood 
cells. In autologous transplants, patients receive their own cells, 
which are removed before chemotherapy or radiation; in alloge-
neic transplants, they can receive stem cells from a closely 
matched family member or an unrelated donor. 
“Of the 35,000 adults and children diagnosed every year with 
leukemia and other life-threatening blood diseases for which  
a marrow or blood stem cell transplant could be a cure, only 
2,500 find a match and receive a transplant,” Bayer says. And 
even the outcomes for those 2,500 are currently far from per-
fect. Whether the transplant results in a cure depends on many 
factors, including the type of cancer, the patient’s age and any  
other illnesses or health problems, how well the donor’s cells 
match, and any complications from the procedure. Generally, 
A LU M N I     N EWS
Bayer is currently running six 
clinical trials focusing on 
improving the outcomes for 
transplantation in five virulent 
forms of cancer.
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the10s
Theresa Devins, M.S. ’01, Dr.Ph. 
’11, was a panelist at a Federal and 
Drug Administration symposium, 
“Dialogues in Diversifying Clinical 
Trials: Success ful Strategies for 
Engaging Women and Minorities in 
Clinical Trials,” jointly sponsored by 
the Office of Women’s Health and 
Society for Women’s Health Research, 
held in Washington, D.C., in September.
Jordan Wicker, M.D. ’10, is com-
pleting his residency in anesthesiol-
ogy at Mount Sinai Hospital in  
New York City.
the00s
Rebecca McAteer, M.D. ’08, com-
pleted her residency in family medi-
cine at Lancaster General Hospital in 
Lancaster, Pa., and is staying on for 
one year as a full-time hospitalist  
with Internal Medicine Hospitalists 
Specialists. She is planning to 
spend time in India this winter doing 
medical missions and community 
development with a Kolkata-based 
organization.
After completing a year as chief resi-
dent in internal medicine at Albany 
Medical College, Wallace J. Wang, 
M.D. ’07, began a fellowship in gas-
troenterology at New York Hospital 
Queens/Weill Cornell Medical 
College in July.
After residency in California, BaoQing 
Li, M.D. ’05, moved back to New 
York with his wife, Zhaohui Li, M.S. 
’01, and their two sons. Dr. Li was 
appointed assistant professor of 
radiation oncology at Weill Cornell  
Medical College and is a full-time  
attending physician at New York 
Hospital in Flushing, Queens.
Julia M. Braza, M.D. ’04, has fin-
ished her first year as an attending 
physician staff member in a private 
pathology practice with her husband 
Anthony Martyniak, M.D., in the 
greater Boston area. They have  
two sons: 18-month-old Anthony, 
and Thomas, who was born in 
November. Dr. Braza subspecializes 
in hema topathology and cytopathol-
ogy but remains busy with general 
surgical pathology and the clinical 
laboratory.
Kamel Ghandour, M.D. ’01 (Fifth 
Pathway), was appointed assistant 
chief of anesthesia at St. Barnabas 
Hospital in New York City.
Arie Pelta, M.D. ’01, is the only board 
certified colon and rectal surgeon at 
Atlanta Medical Center. He is on the 
full-time teaching staff in the AMC 
general surgery program and is an 
associate professor of surgery at the 
Medical College of Georgia.
After completing four years of gen-
eral surgery at Washington Hospital/
Georgetown University, Deepak 
Sudheendra, M.D. ’01, completed 
a radiology residency at the Uni ver-
sity of Pittsburgh Medical Center and 
a fellowship in interventional radiol-
ogy at George Washington University 
Medical Center. Dr. Sudheendra is 
currently assistant professor of inter-
ventional radiology and surgery at 
the Hospital of the University of 
Pennsylvania.
the90s
Scot G. McAfee, M.D. ’97, was pro-
moted to vice chairman, education 
though, the treatment is about 50 percent successful—far  
better, Bayer observes, than when she started in the field in  
the mid-1990s.
The program that Bayer directs at Monter Cancer Center can 
handle some 75 transplants a year in adult patients. It is one  
of only 159 programs worldwide that are accredited by the 
Foundation for the Accreditation of Cellular Therapy (FACT),  
and the only one accredited in Brooklyn, Queens and Long 
Island. The program is a National Marrow Donor Program 
Transplant and Collection Center. Bayer also heads the North 
Shore University Hospital stem cell laboratory.
She is very involved in caring for patients, not only performing 
their transplant procedures but also offering the compassionate 
support essential for people with such life-threatening conditions. 
In another New York Medical College connection, some of Bayer’s 
patients are referred to her by her husband, Frank Cacace, M.D. 
’92, whom she met when they were medical students. He is a 
primary care internist at North Shore University Hospital and 
associate program director of the NS/LIJ internal medicine resi-
dency program.
Bayer is currently running six clinical trials focusing on improving 
the outcomes for transplantation in acute myeloid leukemia, 
acute lymphoblastic leukemia, multiple myeloma, non-Hodgkins  
lymphoma and chronic lymphocytic leukemia. “It’s amazing how 
quickly the field has changed,” she marvels. For many years,  
it was thought that before performing a transplant, ablative 
treatment—high doses of chemotherapy and radiation—were  
required to kill any cancer cells. Now, though, some patients 
receive a reduced intensity treatment that relies on chemotherapy 
to get the disease under control but does not necessarily wipe 
out the marrow. This enables older patients or those with other 
co-existing medical conditions to more safely receive a transplant.
Her research is also exploring ways to control graft-versus- 
host-disease (GVHD), which occurs when the donor’s bone 
marrow/stem cells attack the recipient’s own healthy tissues. 
She calls this potentially fatal problem “the bane of our exis-
tence.” Researchers have labeled T cells the culprit in GVHD, 
but Bayer thinks that the study of B cells, which influence the  
T cells, might be a better place to look for answers.
In her clinical practice and research, Bayer is uplifted by  
the resilience of the human spirit that she sees in her patients, 
and by the strength and compassion of her transplant team.  
“In my lifetime we will continue to see major advances in the 
field of transplantation,” she vows. “I think that eventually we’ll 
have it perfect.” n
M il estones
ALUMNI ACHIEVEMENTS
In this section of Chironian, we publish Class Notes sent by 
our readers. News items should be brief, timely—and 
legible! Submit Class Notes online at www.nymc.edu/
AlumniAndDevelopment/Secure/address.asp, or mail to 
Alumni Relations, New York Medical College, 40 Sunshine 
Cottage Road, Valhalla, NY 10595. Be sure to look for  
us on Facebook and Twitter. Our handle is @NYMC_tweets.
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and director, residency training at 
the Department of Psychiatry  
at Maimonides Medical Center  
in Brooklyn.
Marc Danziger, M.D. ’92, is a part-
ner of New York Urological Associ-
ates in New York City and has a 
special interest in robotic prostate 
cancer surgery.
Richard Kaiser, M.D. ’91, and 
Elizabeth Peters Kaiser, M.D. ’91, 
celebrated their 20th anniversary. 
They were married one week after 
graduation from NYMC.
Charlotte Nutt Hagan, M.D. ’90, 
loves the rural life in southwest 
Virginia. The mother of three chil-
dren—two of them in college—she 
practices in Roanoke.
Renee Kohanski, M.D. ’90, has 
published her novella Cheat Show,  
a psychological autopsy of marriage 
and relationships. She can also be 
heard on www.podjockey.com. Her 
husband, Phillip Kohanski, M.D. 
’87, is now chief of the Department 
of Radiology, Backus Hospital in 
Norwich, Conn.
the80s
Donna Gallagher, M.D. ’89, now 
divorced, works as a radiologist at 
Regional Radiology in Staten Island, 
N.Y., and is an NYMC assistant pro-
fessor of radiology at Richmond 
University Medical Center. 
Gregory Jarrin, M.D. ’89, has 
enjoyed working with the Indian 
Health Service with the Navajo and 
Hopi for more than 13 years. 
Michelle A. (Grosz) Multz, M.D. 
’87, works full time at Huntington 
Hospital. She reports that her hus-
band is chairman of medicine at 
Nassau University Medical Center; 
daughter Rachel is a junior in high 
school; and son Daniel just started 
middle school.
Neil Mitchell Rofsky, M.D. ’85, 
was inducted as a fellow in the 
American College of Radiology. He  
is professor and chairman of radi-
ology at the University of Texas 
Southwestern Medical Center.
Mark J. Cerbone, M.D. ’84, Kevin 
C. Delahanty, M.D. ’84, and Mario 
Tagliagambe, M.D. ’84, were 
almost successful in this year’s 
annual feats-of-strength endeavor. 
During the summer, while trying  
to swim the width of all five of the 
Great Lakes, one aquanut developed 
a cramp. In keeping with their spirit 
of one-for-all, the challenge was put 
on 2012’s calendar.
James A. Deutsch, M.D., ’84, is a 
professor at SUNY Downstate where 
he is director of pediatric ophthalmol-
ogy at Kings County Hospital and 
Long Island College Hospital. He writes, 
“I have kept my private practice at 
half time. My daughter, Emily, is pre-
med at Emory Univer sity in Atlanta.”
Amy Batterman, M.D., ’83, reports 
her daughter Lisa will be in her alma 
mater Hobart & William Smith Class 
of 2015, joining her sister Rebecca, 
Class of 2013.
Jeffrey Krupen, M.D. ’82, writes, 
“Finally finished with tuitions. Two 
lawyers and one computer animator, 
19 years of tuition—done!”
Malcom Z. Roth, M.D. ’82, was 
named president of the American 
Society of Plastic Surgeons and chief 
of the Division of Plastic Surgery at 
Albany Medical Center.
George V. Tsimoyianis, M.D. ’82, 
is looking forward to the 30th 
reunion, especially since his daugh-
ter Christie Tsimoyianis will be grad-
uating in the Class of 2012.
Alan Conrad, M.D. ’81, advanced 
to fellowship status in the American 
College of Healthcare Executives.
Ron LoPinto, M.D. ’81, is one of the 
first surgeons in the northeast to per-
form cataract surgery utilizing the first 
FDA-approved laser for cataract sur-
gery. He lives in Manhasset, N.Y., with 
his wife Jennifer and four children.
Victor L. Modesto, M.D. ’81, is 
currently working for the Orlando 
Veterans Administration as a general 
and colorectal surgeon.
the70s
Roger Madris, M.D. ’79, was 
elected to the Board of Governors  
of the NYMC Alumni Association.
Katha Rossein, M.D. ’78, and 
Ronald Razzore, M.D. ’78, are 
proud new grandparents to Andrew 
Parker Razzore, born March 27, 2011.
A LU M N I  N E W S
FROM PATHOLOGY LAB TO 
EDITING DESK
Alicia Prater, Ph.D. ’07
By Cynthia A. Read
Serendipity—which might be defined as a fortuitous accident—
can play an important role in scientific research. It can also land 
a person in an unexpected (but in hindsight perfectly natural) 
career and place to live. And so it is that both serendipity and 
skill have taken Alicia Prater, Ph.D. ’07, from the pathology labo-
ratory at New York Medical College to a small town in northern 
New Hampshire, where she has forged a successful career as  
a medical writer and editor.
After receiving her Bachelor of Science in biochemistry from 
Indiana University in 2002, Prater came to the College to focus 
on genetics and molecular biology. While working toward her 
Ph.D. in experimental pathology and writing her dissertation on 
the genetic mechanisms underlying hypertension, she was also 
a teaching assistant and lecturer for several graduate pathology 
courses. By the time she finished her degree, however, she had 
grown weary of the intense, narrow focus of her life.
She knew that, should she continue doing research as a post 
doctoral fellow, it would be another long five years before she 
would be, as she put it, “in the driver’s seat.” Intensifying the 
pressure was the economic downturn in 2007, which rendered 
both fellowships and teaching jobs increasingly hard to find. So 
Prater decided to take some time away from hands-on science.
Almost by chance, she came across a Craigslist posting from  
a company called San Francisco Edit. They were looking for a 
Ph.D. with a genetics background who could help non-native-
English speaking scientists polish their research papers for peer- 
reviewed journals. Her degree and background gave her just the 
credentials they were looking for—a happy accident indeed—
and since March 2008 she has worked for San Francisco Edit 
as an independent contractor. Her assignments include editing, 
proofreading, and bringing papers into accordance with the  
target journal’s style guidelines, which are not always easy to 
find, she observed.
The company’s clients come from all over the world, and Prater 
has worked on papers by scientists from China, South Korea, 
South America, the Netherlands and several Nordic countries, 
among others. Through networking and other outreach, she  
has also found her own clients. Several of these, with whom she 
first worked when they were Harvard post-docs, have now gone 
on to start biotech companies, and Prater has helped them with 
other writing tasks like website copy and capabilities brochures.
She always enjoyed writing, says Prater, and had dabbled in 
poetry and fiction. But she says her skills in academic and  
medical writing were well-honed during her years at New York 
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Douglas A. Byrnes, M.D. ’77,  
has been president of the medical 
staff at North Shore LIJ Huntington 
Hospital since January 2010.
Stuart J. Kaufman, M.D. ’77, has 
been happily married to Debby for 
34 years. Their daughter Jaclyn 
married Ross Karel on May 29, 2011 
and is a global treasure analyst in 
Chicago. Their son Jonathon is a 
second-year ophthalmology resident 
at Texas Tech and will be joining 
Stuart’s ophthalmology practice  
in Tampa.
Robert C. Hock, M.D. ’76, has 
been practicing in the Rockville 
Centre, N.Y., area for more than 31 
years and has been chairman of  
OB/GYN at South Nassau Hospital 
for 20 years. He and his wife Peggy 
are about to retire to sunny south-
west Florida, where they have had a 
home for several years. They have  
a 31-year-old son who recently  
returned from his third deployment 
in the Middle East with the U.S. 
Navy. Stationed in San Diego, he  
will be getting married next year.
Bernard Powers, M.D. ’76, had a 
great trip to Vietnam to participate  
in a teaching cultural exchange.  
“It’s a big world and we have a lot  
to learn,” he writes.
Robert A. Stern, M.D., ’76, reports 
he and Anita now have four grand-
children—Eli, Judah, Maxwell and 
finally a princess, Lana Rose. He is  
still practicing OB/GYN in Pough-
keepsie, N.Y.
David Huang, M.D. ’75, is the 
proud grandfather of two—Cole  
Kim and Ryan Kim.
John Stinson, M.D. ’75, left his 
clinical practice of orthopedic surgery 
after 30 years and is now a medical 
officer with the FDA, working on the 
development of new bone drugs.
Edward Swibinski, M.D. ’75, was 
recently appointed clinical professor 
of medicine, division of endocrinology, 
on the faculty of Cooper Medical 
School of Brown University.
Alan S. Sacerdote, M.D. ’74,  
co-authored a chapter entitled 
“Latest Therapeutic Advances in  
the Treatment of Congenital Adrenal  
Hyperplasia in Adolescents and  
Adults” in the newly published book 
Amenorrhea.
John A. Ambrose, M.D. ’72, and 
his wife of 41 years, Avis, lifelong 
New Yorkers, have discovered the 
wonders of California. He is chief of 
cardiology at UCSF, Fresno, program 
director of the cardiology fellowship 
program and professor of medicine 
at UCSF. They live in Fresno and 
have a weekend home on the coast 
of Monterey. He continues to travel 
yearly to Europe and South America  
to lecture on coronary artery disease.
Robert A. Peinert, M.D. ’70, retired 
from practice after his wife died, but 
eventually got very bored. He’s now 
“back in the grind” in Las Cruces, 
N.M., dividing his time between frac-
ture surgery and trout fishing.
Donald E. Sawyer, M.D. ’70, is 
currently working just three days per 
week and enjoys the extra time off. 
He likes seeing patients too much to 
retire completely. “My wife Anne is 
in an extended care facility with a 
rare variant of Alzheimer’s. It is hard 
to watch her drift away,” he writes.
the60s
Richard Hirsh, M.D. ’69, recently 
celebrated his 50th high school 
reunion for the Great Neck North 
Senior High School Class of 1961. 
“Two of my high school classmates 
are also my NYMC classmates: 
Kenneth Hodor, M.D. ’69 and 
Michael L. Bernstein, M.D. ’69. 
Small world!” he writes.
Mark L. Rosenblum, M.D. ’69, has 
been appointed director of a novel 
Health Services Innovation Center  
at Henry Ford West Bloomfield 
Hospital, where he also serves as 
vice president of clinical programs. 
He continues as the chairman of the 
Department of Neurosurgery and 
Neuroscience Institute and Hermelin 
Brain Tumor Center. He and his wife 
Pam live in a Detroit suburb along 
with their two children, their spouses 
and three grandchildren.
Richard Fogler, M.D. ’68, com-
pleted his 14th year as chairman of 
surgery and chief medical officer at 
Brookdale Hospital Medical Center in 
Brooklyn, N.Y., and became chairman 
emeritus in July 2011. He continues 
Medical College. Soon after graduation, when she began to 
explore her options beyond biomedical research, she began 
participating in science discussions she found online. Soon she 
was contributing articles. She is now the Medical Sciences 
Channel Manager and leader of the fact checking team at 
Helium.com, as well as a contributing writer, and is the AIDS/
HIV topic editor at Suite 101.com. Her own website and blog, 
Maeflowers, started as a personal home page when she was an 
undergraduate, and evolved into a site to connect the general 
public with validated medical information. She currently tweets 
under the handle @Maeflowersblog and issues a daily research 
roundup to her followers.
From her early years in Indiana, to New York for graduate school, 
to a brief stint in Raleigh, N.C., Prater now calls northern New 
Hampshire home. She fell in love with New England when visit-
ing family in 2008 and started looking for a place to rent in the 
Concord, N.H., area. There serendipity struck again: to counter-
act a disappointing house search, she and her partner decided 
to take a drive up through the mountains, where they happened 
on Littleton, and immediately knew they’d found their spot. 
Much like leaving laboratory research and becoming an editor 
and writer, says Prater, although she knew what she didn’t 
want, she didn’t know what she’d say yes to until she found it.
Sometimes you do find that “yes” by serendipity. But Prater 
wishes she had paid more attention to all that was available at 
the College. She offers this advice to current students: “Don’t 
just focus on the narrow topic of your degree. Learn as much 
as you can from the people around you in other departments—
you never know where that might lead.” n
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A LU M N I  N E W S
TAKING CARE OF THE BUSINESS  
OF HEALTH CARE
Jason Tenzer, M.P.H. ’04, wields medical knowledge 
and business savvy to forge a path to leadership.
By Melissa F. Pheterson
Even as a student, Jason Tenzer, M.P.H. ’04, caught a glimpse into his future career 
while talking with classmates and professors about their jobs in the health care industry.
“By bringing real-world experience to the classroom, they gave me knowledge that went 
far beyond the textbook,” he recalls. “Looking back, it was one of the greatest strengths 
of my education.”
After graduating from the Health Policy and Manage ment program in the School of 
Health Sciences and Practice, Tenzer joined Mt. Sinai Medical Center as an administrator 
over seeing staff and operations. While there, he completed a rigorous training program 
in Lean Six Sigma, a business management strategy originally used by Motorola and 
GE. “The reasoning was, if Six Sigma works in industry, why not in medicine?” Under 
the program, he completed a project that entailed improving efficiency and “patient 
throughput” in Mt. Sinai’s endoscopy suite. “We sat in the unit day after day, timing the 
whole process of the procedures.” Tenzer’s recommended improvements to maximize the 
practice included an electronic alert system that paged doctors when the room was ready.
“AHEAD OF THE CURVE”
In his next job as administrator at New York University’s Langone Medical Center, 
Tenzer joked he felt like “the Lone Ranger” while running his own department, at the 
Center for Arthritis and Autoimmunity. “I used what I learned to make improvements,” he 
says. “I felt like I was ahead of the curve in quality improvement.” Among the problems 
he solved was pinpointing, and changing, an inefficient phone system at the Center— 
a case study he often describes in presentations. “Six Sigma,” he says, “is an organized 
way of digging through the layers of a problem.”
As of last May, Tenzer serves as director of physician practice management at Metro-
politan Jewish Health System in Brooklyn. His ascent through the ranks of health care has 
proved a secure and successful career move. He calls it “a leap of faith” that inspired 
as chief medical officer with a specific interest 
in quality issues.
Albert J. Bajohr Jr., M.D. ’67, retired from 
private practice in vascular surgery in January 
2009. “Life is wonderful—six months in Florida 
and six months on Long Island. We travel a lot 
to Italy and are very much enjoying our four 
sons and four grandchildren,” he reports.
Morton Meltzer, M.D. ’65, gave up urgent 
care and is just practicing psychiatry now.
Barry E. Nash, M.D. ’65, is retired. He and 
his wife Muriel have four children—Eric, 
Michael, Eileen and Heather—and seven 
grandchildren.
Alan Wecksell, M.D. ’65, writes, “Retirement 
is great!”
Howard Cooperman, M.D. ’63, is enjoying 
retirement in Santa Barbara with Trudy, his 
wife of 54 years. He spends his time painting, 
printmaking, traveling and spending time with 
his family, which includes 10 grandchildren. 
“Life is good,” he writes.
Robert A. Bennett, M.D. ’62, is fully retired. 
Painting, book club, investments and travel 
keep him occupied.
Mark Levey, M.D. ’62, is retired and doing 
well with six grandchildren.
Barry S. Meltzer, M.D. ’62, is looking for-
ward to the 50th reunion in May. He is retired 
since 2008 and loves to travel. He is involved 
in town politics and enjoys live theater.
Alan L. Rubinstein, M.D. ’62, is enjoying 
retired life in Florida. “I am looking forward to 
the 50th reunion. I will miss Norm Katz, 
[M.D. ’62], Bill Tesauro, [M.D. ’62] and 
Lester Berkow, [M.D. ’62],” he wrote.
Robert D. Hirsch, M.D. ’61, has been fully 
retired for four years now and is spending 
more time in Sarasota, Fla., with his wonderful 
wife. He enjoys the cultural arts and liberal edu-
cation classes he never had time for in medical 
school and in 41 years of a busy practice.
the50s
Howard Kline, M.D. ’58, received a Special 
Recognition Award for outstanding teaching 
contributions as a member of the clinical fac-
ulty from the University of California, San 
Francisco, School of Medicine. He still actively 
practices cardiology in San Francisco and is  
a competitive swimmer for the University of  
San Francisco Masters Swim Team. His son 
Christopher Koontz, M.D. ’10, is in his second 
year of surgical residency in New York City.
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him to leave the familiar environment of academic medicine to 
take a job in a health system that focuses on providing mostly 
ancillary services. His daily activities include business planning, 
financial management and development of infrastructure and 
processes to support the system’s physician practices. He 
admittedly spends much of his time dealing with administrative 
minutiae. “Since my job cuts horizontally across all facets of the 
organization, I spend lots of time organizing the troops,” he 
says. But it fits in with his boyhood aspirations. “As a kid, I 
always loved to fix and reengineer anything I could get my 
hands on, and I have never really stopped. I think working in 
health care at the present time is giving me the greatest oppor-
tunity I’ve ever had to help fix something that every person in 
this country is paying attention to.”
Tenzer credits the student experience in the School of Health 
Sciences and Practice with helping him navigate the industry. 
“Because we had strong relationships with our professors, with 
many students and teachers working in the field, I had the 
opportunity to get face-time, learn to network and become  
what I wanted to be,” he says. “The education I got was excel-
lent. But it was those intangibles, those extracurriculars, that 
gave me skills beyond basic book knowledge.”
GIVING BACK
Tenzer has made a commitment to mentoring students and new 
graduates, speaking at health care leadership summits and 
New York Medical College alumni seminars. “I remember being 
one of those new grads, trying to find my way, wanting a peer—
and it shaped my wanting to give back, reach out, and help stu-
dents.” During his years of graduate study, Tenzer was president 
of the student chapter of the American College of Healthcare 
Executives. “Now I’m an ingrained member,” he says. “I’ve spo-
ken at national conferences and mentored groups locally. It’s 
turned out to be one of the best things for my career.”
The faculty advisor for the group, Deborah Viola, Ph.D., M.B.A., 
associate professor of public health practice, stands out in 
Tenzer’s mind for playing a key role in the devel opment of his 
career. “She recognized that I could give the extra mile,” Tenzer 
recalls, “and pushed me to do it.” In fact, when a board seat 
opened up on a local chapter of health care executives, Tenzer 
decided to throw his hat in the ring for the elected seat—and 
was rewarded with his first win. “Sometimes we all need that 
push,” he says.
An avid scuba diver, Tenzer has taken vacations just to explore 
tropical waters. “Diving is my connection to my scientific back-
ground, to make sure it doesn’t fade away,” he says. Tenzer 
received his biochemistry degree from SUNY Purchase in 2001, 
and had once hoped to study marine biology. “Diving is a highly 
technical hobby, yet it forces me to take time off. My BlackBerry 
does not work underwater! And because I literally immerse 
myself in it, it’s a great way to keep balanced.” n
IN MEMOR IA M
Alumni
Matthew R. Curley, M.D. ’09,  
died August 29, 2011. He was 28.
Marc H. Horowitz, M.D. ’92,  
died June 7, 2011.
Anthony G. Giatras, M.D. ’91,  
died July 17, 2011. He was 51.
Richard L. Blitz, M.D. ’88, died 
November 23, 2011. He was 51.
Lawrence Woode, M.D. ’87,  
died June 20, 2011.
Joseph J. Altieri, M.D. ’82,  
died June 6, 2011.
Steven Forst, M.D. ’77, died  
June 21, 2011. He was 59.
John J. Hughes, M.D. ’71, died 
April 27, 2011.
William E. Tesauro, M.D. ’62,  
died November 7, 2011.
Nicholas A. Conforti, M.D. ’61, 
died November 1, 2011. He was 81.
William F. Grant Jr., M.D. ’61,  
died April 27, 2011. He was 76.
Edwin S. Stempler, M.D. ’61,  
died August 5, 2011.
Roger L. Hinkson, M.D. ’60,  
died June 18, 2011.
Timothy C. Zoba, M.D. ’59,  
died May 19, 2011.
Donald J. Bradley, M.D. ’56,  
died October 18, 2011.
Theodore Jacobs, M.D. ’55,  
died May 15, 2011. He was 81.
Edmund W. McGrath, M.D. ’55, 
died October 18, 2011. He was 81.
Arthur S. Campbell, M.D. ’54,  
died July 9, 2011. He was 83.
Richard Fisch, M.D. ’54, died 
October 23, 2011. He was 84.
Thomas J. Weber, M.D. ’54,  
died September 21, 2011.
John E. Aiken, M.D. ’53, died 
December 6, 2011.
David H. Darling, M.D. ’53, died 
February 6, 2011. He was 83.
Jay P. Sackler, M.D. ’53, died 
September 19, 2011. He was 83.
John T. Sheridan, M.D. ’53,  
died July 20, 2011.
George R. Walker, M.D. ’53,  
died June 9, 2011. He was 87.
Robert E. Gaffney, M.D. ’52,  
died July 3, 2011. He was 88.
John P. McCloy, M.D. ’52, died 
May 14, 2011.
Arthur G. Sullivan, M.D. ’52,  
died December 12, 2011.
Colonel (USA Ret.) Henry T. Uhrig, 
M.D. ’51, died November 17, 2011.
Leonard M. Rapoport, M.D. ’50, 
died March 20, 2011. He was 89.
Milton Olf, M.D. ’49, died 
September 24, 2011. He was 90.
Alvin M. Donnenfeld, M.D. ’48, 
died June 24, 2011. He was 86.
Richard H. Lange, M.D. ’48, died 
September 5, 2011. He was 87.
Robert J. Suozzo, M.D. ’48, died 
October 6, 2011. He was 88.
Leonard Biel Jr., M.D. ’46, died 
February 25, 2011. He was 89.
Warren W. Daub, M.D. ’46, died 
May 26, 2011. He was 87.
Eugene E. Gaudet, M.D. ’46, died 
November 4, 2011. He was 92.
Ciro S. Tarta, M.D. ’43, died  
March 25, 2011. He was 94.
William Rubin, M.D. ’37, died 
November 4, 2011.
 Faculty
Jules R. Bemporad, M.D., clinical 
professor of psychiatry and behav-
ioral sciences, died June 3, 2011.
Fey Chu, M.D., emeritus clinical 
associate professor of surgery, died 
May 24, 2011 at the age of 95.
Peter B. Engel, M.D., assistant pro-
fessor of psychiatry and behavioral 
sciences, died August 28, 2011 at 
the age of 53.
Lawrence C. Miller, M.D., clinical 
associate professor of psychiatry 
and behavioral sciences, died June 
29, 2011 at the age of 86.
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David Lehr, M.D. 
1910–2010
David Lehr, M.D., professor emeritus of the Depart-
ment of Pharmacology, died October 4, 2010, at the 
age of 100. A member of the faculty for more than 40 
years, he joined the College in 1940 as an instructor  
in the Department of Medicine. He subsequently rose 
to become the first chairman of the Department of 
Pharmacology, which he founded, serving in that 
capacity for 25 years.
Born and educated in Vienna, Austria, David Lehr 
achieved international recognition as a physician  
scientist, educator and scholar, authoring more than 
370 scientific publications throughout his long and 
productive career. One of his earliest contributions 
was to demonstrate that a “triple sulfonamide mix-
ture,” i.e., a one-third effective dose of each of three 
sulfonamide antibiotics, could essentially eliminate the 
risk of renal toxicity that was a common side effect of 
a full dose of a single sulfonamide. His work was an 
early demonstration of a common dogma in therapeu-
tics today, of using combinations of drugs that add 
their respective efficacies, but “dilute” their toxicities.
He was a survivor of the Holocaust, and often alluded 
to a stroke of luck which helped him escape the Nazi 
takeover of his native Vienna during the Anschluss. A 
renowned lecturer and scholar, in 1938 Dr. Lehr was 
invited to spend a year teaching in Sweden just prior 
to the Nazi occupation, and thus managed to escape 
with his family to that country. He later wrote about 
these experiences in his book, Austria Before and 
After the Anschluss, which was published in 2000 and 
earned him significant honors.
On the occasion of Dr. Lehr’s 90th birthday, New York 
City Mayor Rudolph W. Giuliani proclaimed March 22, 
2000, to be Dr. David Lehr Day in the City of New 
York, and the street where he lived as David Lehr, 
M.D., Boulevard.
He is survived by his wife of 45 years, Lisa Lehr, who 
was employed by the College from 1966 to 1983.
Albert Willner, M.D. ’43 
1918–2011
Albert Willner, M.D. ’43, former College trustee,  
died on November 16, 2011, at the age of 93. From 
the day he became a physician, Dr. Willner ardently 
believed he owed a debt of gratitude to New York 
Medical College for giving him the education he 
needed to succeed. Throughout his entire career he 
worked tirelessly to repay that debt—even donating 
the first paycheck he earned as a physician to the 
College. He was active in the Alumni Association for 
more than four decades, joined the Board of Trustees 
in 1996, and was a member of the President’s National 
Advisory Council.
Dr. Willner and his wife Blanche were generous sup-
porters of the medical student scholarship program, 
often responding to needs they learned about on  
their visits to campus by underwriting various campus 
facilities and structures. In the late 1990s Dr. Willner 
and his family donated funds to build a playground  
in student housing, and later funded the renovation 
and construction of the atrium lobby of the Medical 
Education Center which is named after the couple in 
honor of their longtime patronage and dedication.
In 2006, the College awarded Dr. Willner the William 
Cullen Bryant medal, in recognition for his distinguished 
and wide-ranging leadership. He once said, “I hope 
that those students who are part of the College today 
will not take the value of [their education] for granted, 
and will help in their own way when they become 
leaders in medicine.”
One of three children born to parents who left Poland 
and came to the U.S. in the 1890s, Albert Willner was 
one of several “Dr. Willners” in his family: his uncle 
Irving (who graduated from New York Medical College 
in 1913), his brothers Philip and Milton, and Albert 
himself, who met his wife, Blanche, on a commuter 
train while attending New York Univer sity as an under-
graduate. Their two children became doctors, and so 
did several grandchildren, a nephew and a grand-
nephew—all told, about one out of three were New 
York Medical College graduates.
He was predeceased by his wife Blanche, and is sur-
vived by his son, Dr. Joseph Willner, daughter Dr. Jane 
Bloomgarden, and numerous nieces, nephews and 
grandchildren, including Noah Bloomgarden, M.D. ’10.
Felix E. Wassermann, Ph.D. 
1924–2011
Felix E. Wassermann, Ph.D., professor emeritus of 
microbiology and immunology, died May 22, 2011, at 
the age of 86. Born in Bamberg, Germany, he lived 
there until the age of 12, when he fled with his family 
to Prague to escape the Nazis. The family moved  
several times in the next few years, first to England, 
then Mexico, finally reaching the United States in 1941.
He served in the army during World War II, and later 
earned bachelor’s and master’s degrees in agricultural 
bacteriology from the University of Wisconsin. He 
returned to the East Coast, where he received a Ph.D. 
in microbiology from New York University. He had one 
more stint in the armed serv ices, working as a bacte-
riological supervisor at Camp Detrick, Md., a job he 
detested, loading dried anthrax spores into artillery 
shells for the Army Chemical Corps for testing as a 
biological weapon.
Dr. Wassermann joined the College in 1965 as an 
assistant professor of virology in the Department of 
Microbiology and Immunology at Flower-Fifth Avenue 
Hospitals in New York City, becoming full professor  
in 1977. Twice he served as acting chairman of the 
Department of Microbiology and Immunology, from 
1970 to 1976 and again from 1999 until 2002.
For 38 years, until he retired from the College faculty 
in 2004, Dr. Wassermann made innumerable contribu-
tions to education and research programs. He was 
instrumental in helping establish the College’s curricu-
lum in medical and research ethics, which he called  
“a passion.” But his dedication to learning, and to the 
individuality of the students he taught, remains his  
legacy: Dr. Wasserman could remember nearly every 
student he ever taught, matching names to faces with  
uncanny recall, and saved every Commencement  
program and yearbook since 1958 until they were 
destroyed in a flood. He was also a devoted family 
man to his wife Hannah and their three sons, Ross, 
Joel and Eric.
T R IBU T ES
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Felicien M. Steichen, M.D. 
1926–2011
Felicien M. Steichen, M.D., professor emeritus of 
surgery, died June 27, 2011, at the age of 84. A mem­
ber of the faculty from 1978 to 2008, Dr. Steichen  
was the first occupant of the eponymous Felicien M. 
Steichen Chair of Surgery and the first director of  
the Institute for Minimally Invasive Surgery, which he 
established. His contri butions to the field of minimally 
invasive surgery and surgical stapling won interna­
tional acclaim and earned him a lifetime achievement 
award as a pioneer in the development of laparo­
scopic technologies and stapling methods.
Born in Luxembourg, Felicien M. Steichen graduated 
first in his class from the Medical School of the Uni­
ver sity of Lausanne in Switzerland. He emigrated to 
the U.S. in 1953 to complete his training at Lakewood 
Hospital in Cleveland and Johns Hopkins University 
School of Medicine in Baltimore. In 1978 he was 
recruited as chief of surgery at College­affiliated 
Lenox Hill Hospital in New York.
Throughout his long and illustrious career Dr. Steichen 
contributed hundreds of articles, books and book 
chapters to the surgical literature, continuing long 
after he had retired from the practice of surgery. In 
1986, he was awarded the Mayor’s Liberty Medal 
from New York City Mayor Edward I. Koch. He was 
elected to a score of European and American surgical 
societies, as well as earning honors from the govern­
ments of France, Luxembourg and Germany. A $1.5 
million grant from the U.S. Surgical Corporation in 
1993 established an endowed chair of surgery in his 
honor at New York Medical College.
In 2003 the College honored Dr. Steichen with its 
Distinguished Service Award. In 2008 he was recog­
nized for his contributions to the technique of surgical 
stapling at the Society of Gastrointestinal and Endo­
scopic Surgeons annual conference, which marked 
the 100th anniversary of the technique.
He is survived by his wife Michele and his three children, 
Anne, Francois and Claire, and five grandchildren. He 
is buried in Brittany, France.
Gabor Kaley, Ph.D. 
1926–2011
Gabor Kaley, Ph.D., professor and former chairman 
of the Department of Physiology, died on December 
15, 2011, at the age of 85. A member of the faculty 
since 1964, he helped establish the Graduate School 
of Basic Medical Sciences, and became chairman  
of the Department of Physiology in 1970. Until he 
stepped down from that post in 2007, he had the  
distinction of being the longest sitting chair of phys­
iology in the nation.
Born in Budapest, Hungary, Gabor Kaley first studied 
medicine, but when war intervened, he was sent to a  
labor camp in Yugoslavia where only 600 of the 6,000 
inmates survived. After the war, he boarded a ship for 
America where he worked as a busboy, cab driver 
and singing waiter to pay for his studies. After receiv­
ing a B.S. in biology at Columbia Univer sity, he was 
drafted into the U.S. Army during the Korean War, and 
later used the GI Bill to earn an M.S. in physiology 
from New York University and a Ph.D. in experimental 
pathology.
During his career Dr. Kaley wrote more than 150 arti­
cles, edited an authoritative three­volume edition of 
Microcirculation, gave invited lectures around the 
world and served on the editorial boards of numerous 
scientific journals. A member of the Hungarian Academy 
of Sciences, he was awarded the Semmelweis Medal 
in 1982 for his work in microcirculation. In 2001 he  
received the Wiggers Memorial Award, which recog­
nizes outstanding and lasting contributions to cardio­
vascular research. He received the Eugene M. Landis 
Award from the Microcirculatory Society in 1994 and 
was named the George E. Brown Memorial Lecturer 
by the Council on Circulation of the American Heart 
Association in 1998. In 2005, he was named an 
Eminent Physiologist by the American Physiological 
Society. The honor resulted in a videotaped interview 
with Dr. Kaley about his life, achievements and vision 
for the future of physiology, a record that is now 
housed in the society’s historical archives.
He is survived by his wife of more than 40 years, 
Harriette Weintraub Kaley, Ph.D., a psychologist  
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